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Maintenance of healthy mitochondria is crucial in cells, such as neurons, with 
high metabolic demands, and dysfunctional mitochondria are thought to be selectively 
degraded. Studies of chemically uncoupled cells have implicated PINK1 mitochondrial 
kinase, and Parkin E3 ubiquitin ligase in targeting depolarized mitochondria for 
degradation. However, the role of the PINK1/Parkin pathway in mitochondrial turnover is 
unclear in the nervous system under normal physiological conditions, and we 
understand little about the changes that occur in the mitochondrial life cycle when 
turnover is disrupted. Here, I evaluated the nature, location and regulation of quality 
control in vivo using quantitative measurements of mitochondria in Drosophila nervous 
system, with deletion and overexpression of genes in the PINK1/Parkin pathway. I tested 
the hypotheses that impairment of mitochondrial quality control via suppression of PINK1 
function should produce failures of turnover, accumulation of senescent mitochondria in 
the axon, defects in mitochondrial traffic, and a significant shift in the mitochondrial 
fission-fusion steady state. Although mitochondrial membrane potential was diminished 
by PINK1 deletion, I did not observe the predicted increases in mitochondrial density or 
length in axons. Loss of PINK1 also produced specific, directionally-balanced defects in 
mitochondrial transport, without altering the balance between stationary and moving 
mitochondria. Somatic mitochondrial morphology was also compromised. These results 
strongly circumscribe the possible mechanisms of PINK1 action in the mitochondrial life 
cycle, and also raise the possibility that mitochondrial turnover events that occur in 








1.1 Mitochondrial Life Cycle in Neurons 
 
1.1.1 Significance of Functional Mitochondria in Neurons 
Neurons, like other cells, depend on mitochondria for their survival and normal 
function. Mitochondria perform diverse functions including generating ATP, controlling 
the release of apoptotic signals and buffering excess cytosolic calcium ions. To provide 
the ATP required for cellular activities, mitochondria harness the energy released by the 
oxidation of nutrients via the electron transport chain (ETC) and oxidative 
phosphorylation (OXPHOS). The mitochondrial inner membrane contains the enzymatic 
complexes required for ETC and OXPHOS processes. In the ETC, as electrons are 
transferred from substrates through complexes I to IV, protons are pumped out of 
mitochondrial matrix into the intermembrane space. This establishes an electrochemical 
gradient, consisting of both a negative membrane potential (IMP or ΔΨm) inside the 
mitochondrial matrix, and a proton gradient (ΔpH) across the mitochondrial inner 
membrane. This electrochemical potential across the membrane has potential energy 
that is harnessed during the inward flow of protons into mitochondrial matrix through 
ATP synthase complex. Thus, the rate of ATP production depends on the mitochondrial 
inner membrane potential (IMP) (Benard and Rossignol, 2008).  
Neurons rely heavily on mitochondrial aerobic ATP production, from which they 
derive the majority of ATP needed for their high metabolic rate. Accordingly, 
mitochondria are distributed and concentrated in neuronal regions with high metabolic 
activity such as synapses, active growth cones, nodes of Ranvier, myelination zones 
etc., to meet local energy demands (Hollenbeck and Saxton, 2005). The enormous size 
and surface area of neurons result in high levels of ATP being consumed for the 
maintenance of ionic gradients and membrane potential associated with Na+/K+ pumps 
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(Knott et al., 2008). In addition, because of their highly polarized and complex 
morphology, neurons depend heavily on axonal transport that utilizes ATP and motor 
proteins to deliver materials and organelles to all parts of the cell. At distal synaptic 
regions, mitochondria supply ATP for many events of the synaptic vesicle (SV) cycle 
including: SV loading of neurotransmitters (NTs); myosin mediated mobilization of SV; 
and the SV fusion with plasma membrane for NT release into synaptic cleft (Vos et al., 
2010). Moreover, mitochondria are known to sequester excess cytosolic calcium ions in 
the presynaptic terminal during synaptic transmission (Vos et al., 2010). Thus many 
mitochondrial functions are known to be essential for the life of the neuron.  
In addition to ATP production, mitochondria generate reactive oxygen species 
(ROS), mainly as a byproduct of ETC. During the process of ETC, superoxide radicals 
(O2•−) can be generated at complexes I and III, by anomalous transfer of electrons to 
oxygen (Turrens, 2003). In healthy mitochondria, ROS are normally maintained at low 
steady state levels due to their reduction by mitochondrial antioxidant enzymes including 
superoxide dismutase and glutathione peroxidase. However, if mitochondria are 
damaged and become dysfunctional, antioxidant enzymes may become insufficient to 
the task, causing the accumulation of ROS. This causes additional damage to proteins, 
lipids, and nucleic acids, eventually leading to gross oxidative stress (Turrens, 2003). 
Oxidative stress is thought to play an important role in age-related progressive 
neurodegenerative diseases such as Parkinson’s disease (PD) and Amyotrophic lateral 
sclerosis (ALS) (Turrens, 2003; Barnham et al., 2004). 
Given the critical dependence of neurons on various mitochondrial functions, 
mitochondrial dysfunction can be expected to have severe effects on neuronal function 
and survival. Indeed, mutations affecting mitochondrial function have been shown to be 
associated with several neurodegenerative diseases including PD, hereditary spastic 
paraplegia (HSP), Charcot-Marie-Tooth type2A (CMT2A) disease etc., (Tatsuta and 






1.1.2 Mitochondrial Quality Control 
Cells employ quality control mechanisms at the molecular and the organelle level 
to maintain the healthy, functional mitochondrial population (Rugarli and Langer, 2012). 
Mitochondrial protein quality control is initiated mainly in response to irreversible 
mitochondrial protein damage or heat stress, and utilizes molecular chaperones and 
AAA proteases. Chaperones help in the proper folding of newly synthesized, imported 
pre-proteins. Most AAA proteases specifically identify misfolded or damaged proteins 
and degrade them into small peptides, which are eventually expelled from mitochondria 
for further degradation to amino-acids by cytoplasmic oligopeptidases (Tatsuta and 
Langer, 2008). At the organelle level, mitochondria maintain their functional status by 
frequently undergoing fusion and fission. Inhibition of mitochondrial fusion in fibroblast 
cells results in reduced mitochondrial function and respiratory capacity (Chen et al., 
2005). These mitochondrial defects can be rescued by induction of mitochondrial fusion, 
suggesting that fusion helps in the maintenance of functional mitochondria in cells (Chen 
et al., 2005; Detmer and Chan, 2007). However, dysfunctional mitochondria are inhibited 
from fusing with the healthy mitochondrial network, and are then thought to be 
eliminated by the process of mitochondrial autophagy, termed “mitophagy” (Twig et al., 
2008b; Rugarli and Langer, 2012).  
An additional issue for a large neuronal cell with complex morphology is the 
localization or compartmentalization of the different parts of the mitochondrial life cycle: 
biogenesis, transport, changes in metabolic state, fission-fusion, and turnover. It is 
presumed that in neurons, as in other cells, these features of the mitochondrial life cycle 
are carried out in a coordinated fashion so as to maintain a highly functional 
mitochondrial population, minimizing the effects of somatic mtDNA mutations, protein 
denaturation, etc. This coordination is commonly referred to as mitochondrial quality 
control. However, we still know very little about how neuron coordinates the events of 






1.1.3 The Mitochondrial Life Cycle in Neurons 
The mitochondrial life cycle in neurons consists of multiple, coordinated events that 
encompass mitochondrial biogenesis, axonal transport, fission-fusion and turnover.  
Neurons have a polarized structure including a cell soma, dendrites, an axon and 
synaptic terminals. The somatic compartment is connected to synaptic region by an 
extremely long, thin axon which can extend up to a meter in human motor neurons. The 
majority of protein synthesis and degradation machinery is concentrated in the neuronal 
somatic compartment, near the nucleus. Consequently, newly synthesized proteins and 
organelles are delivered from the soma to the axonal and synaptic regions by 
anterograde axonal transport. The damaged, worn-out materials and organelles are 
moved by retrograde transport back to the soma for recycling and degradation (Saxton 
and Hollenbeck, 2012).  
1.1.4 Mitochondrial Biogenesis  
Mitochondria possess their own genome that encodes 13 essential protein subunits of 
ETC, along with 2 rRNAs and 22 tRNAs required for mitochondrial protein synthesis 
inside the organelle. Each mitochondrion contains several copies of mitochondrial DNA 
(mtDNA). Mitochondrial DNA is packaged along with mtDNA-associated proteins into 
nucleoid structure. The core components of nucleoid structure mainly include proteins 
and enzymes required for mtDNA replication, and transcription (Gilkerson et al., 2013). 
However, the majority of the mitochondrial proteins are encoded by nuclear genome, 
including mitochondrial structural proteins and proteins required for mtDNA replication 
and transcription. These nuclear DNA encoded proteins are translated in the cytosol, 
and imported into mitochondria through protein translocase complexes, TOM and TIM, 
present in outer and inner mitochondrial membrane (Jornayvaz and Shulman, 2010). 
Thus mitochondrial biogenesis requires close coordination between mitochondrial and 
nuclear genomes. This coordination is not fully understood, but it is known to be 
regulated by transcriptional activators including PPAR (peroxisome proliferator-activated 
receptor)-γ coactivator-1α (PGC-1α) along with transcriptional coactivator nuclear 
respiratory factors (NRF-1 and NRF-2). PGC-1α activates NRFs, which then induce the 
expression of mitochondrial transcription factor A (Tfam). This nuclear-encoded Tfam is 
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imported into mitochondria, where it initiates the transcription of mtDNA (Duchen, 2004; 
Jornayvaz and Shulman, 2010). Because of this complex coordination between 
mitochondrial and nuclear genomes, mitochondrial biogenesis is thought to occur 
predominantly in cell soma, near the nucleus. Given the lengthy dimensions of neuron, 
the newly generated mitochondria are then delivered from cell soma to active neuronal 
regions by fast axonal transport. However, mitochondrial biogenesis is not restricted to 
somatic compartment, and evidence from embryonic neurons indicates that it can also 
occur in axons (Amiri and Hollenbeck, 2008).  
1.1.5 Mitochondrial Axonal Transport  
Because of the size and compartmentalized structure of neurons, an ATP supply 
provided by diffusion from the soma is entirely insufficient to support neuronal activities. 
Therefore, mitochondria are positioned all along the axon and are also concentrated at 
distal synaptic regions, active growth cones, nodes of Ranvier, myelinated regions etc., 
to manage local metabolic demands (Hollenbeck and Saxton, 2005). Compared to other 
axonal cargoes, mitochondria show distinctive saltatory and bidirectional movements in 
the axon. Mitochondrial movements include stops, starts and small reversals in direction 
(Hollenbeck and Saxton, 2005; Saxton and Hollenbeck, 2012). However, mitochondria 
spend the major fraction of time moving in their primary direction compared to pauses or 
reversals which result in their strong net movement in one particular direction (Morris 
and Hollenbeck, 1993; Pilling et al., 2006; Shidara and Hollenbeck, 2010). In addition, 
mitochondrial movement has been shown to be highly regulated in response to regional 
physiological requirements of neurons (Morris and Hollenbeck, 1993; Hollenbeck, 1996). 
In an actively growing axon, mitochondria show net anterograde movement and are 
retained in high densities near the growth cone region. However, when the axonal 
growth has been disrupted either physically or pharmacologically, mitochondria showed 
net retrograde movement and are uniformly dispersed along the axon, far from the 
growth cone region (Morris and Hollenbeck, 1993).  
These complex movements are accomplished with the help of trafficking 
machinery that includes molecular motor proteins that carry mitochondria along 
cytoskeletal tracks. Long distance axonal transport of mitochondria occurs on 
microtubule tracks (MTs) that are arranged with their plus ends towards the synaptic 
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terminals and minus ends towards the cell body. Plus end-directed conventional kinesin 
(kinesin-1) acts as the major anterograde motor and minus end-directed dynein acts as 
the retrograde motor. Inhibition of mitochondrial movement in the absence of kinesin-1 
and dynein in the Drosophila nervous system suggests that kinesin-1 and dynein act as 
the major motors in the axonal transport of mitochondria (Pilling et al., 2006).  
In addition to MTs, actin filaments have also been shown to be involved in 
mitochondrial axonal transport based on the observation of mitochondrial motility after 
the pharmacological disruption of MTs (Morris and Hollenbeck, 1995). Thus it has been 
postulated that actin filament based transport might facilitate the short range movement 
of mitochondria locally in regions that lack MTs (Morris and Hollenbeck, 1995). However, 
disruption of Myosin V in Drosophila cultured neurons caused a decrease in pausing 
time and an increase in the mitochondrial movement suggesting a role for myosin 
motors in mitochondrial docking by opposing the MT based transport (Pathak et al., 
2010) (Figure 1.1).   
 
Figure 1.1 Tracks and motors in mitochondrial axonal transport. (a) Mitochondria 
are transported on microtubule tracks for long distances in axons by anterograde 
Kinesin-1 and retrograde dynein motor proteins. (b) Actin filament based Myosin V motor 
protein assists in stationary docking of mitochondria by opposing microtubule based 
organelle movements. (Figure is adapted and modified from Saxton and Hollenbeck, 
2012).  
Mitochondrial axonal transport is also specifically regulated by intracellular 
signals, perhaps to ensure the efficient delivery of mitochondria to appropriate locations. 
Application of nerve growth factor (NGF)-coated beads to axonal regions has been 
shown to cause the local halting of mitochondrial movement near the NGF signal. 
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However, the NGF mediated mitochondrial halting is disrupted by the inhibition of 
phosphoinositide-3 kinase (PI-3 kinase) pathway suggesting that the NGF/PI-3 kinase 
signaling pathway facilitates mitochondrial docking on actin filaments (Chada and 
Hollenbeck, 2003; Chada and Hollenbeck, 2004). In addition, a variety of kinase 
signaling pathways have been shown to regulate fast axonal transport of organelles by 
phosphorylating specific motor protein subunits. GSK3 and CK2 have been shown to 
phosphorylate kinesin light chains (KLCs) causing the release of kinesin motor from the 
organelle, thereby inhibiting anterograde transport (Morfini et al., 2002; Morfini et al., 
2004). Phosphorylation of kinesin heavy chain (KHC) by JNK3 and p38 MAPK has been 
shown to inhibit the motor head domain from interacting with MTs thus disrupting 
anterograde transport (Morfini et al., 2009a; Morfini et al., 2013).   
Axonal transport is also regulated by adaptor or linker proteins that associate an 
organelle to its motors. Genetic screens in Drosophila designed to identify genes 
required for synaptic transmission surprisingly uncovered the function of Milton (Stowers 
et al., 2002). Drosophila milton mutants have a complete lack of mitochondria in their 
axons and synaptic terminals, resulting in synaptic functional deficits. The association of 
Milton with both mitochondria and kinesin suggested a role in mediating the axonal 
transport of mitochondria (Stowers et al., 2002). Similarly, Drosophila miro mutants have 
also shown a complete lack of mitochondria in synapses, causing defective synaptic 
transmission (Guo et al., 2005). In the absence of Miro, mitochondria accumulate in cell 
bodies, with a sparse distribution in axons, indicating a role for Miro in mitochondrial 
transport (Guo et al., 2005). Similar to miro null mutants, deletion of N-terminal GTPase 
domain of Miro also causes the mitochondrial accumulation in cell bodies with very few 
mitochondria entering the axons (Babic et al., 2015). This suggests that N-terminal 
GTPase domain of Miro plays a crucial role in the transport of mitochondria into axons 
(Babic et al., 2015). Milton, via an interaction with Miro, has been shown to act as an 
adaptor protein complex that recruits kinesin-1 motor onto the mitochondrial surface 
(Glater et al., 2006). In addition to rho-GTPase like activity, Miro possesses calcium 
binding EF-hand domains, and has been shown to regulate mitochondrial transport 
machinery in response to elevated intracellular Ca2+ ions. Binding of Ca2+ to EF-hands 
causes a conformational change in Miro that results in its direct binding to the kinesin-1 
motor domain, thereby preventing the kinesin-1 motor from interacting with MTs (Wang 
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and Schwarz, 2009). Thus, Miro has been proposed to have a role in halting 
mitochondrial movement in response to the elevated Ca2+ levels in neurons (Wang and 
Schwarz, 2009).  
Impaired mitochondrial transport is known to be associated with the 
pathogenesis of multiple neurodegenerative diseases including Huntington’s disease 
(HD), hereditary spastic paraplegia (HSP), and familial amyotrophic lateral sclerosis 
(ALS) (De Vos et al., 2008; Sheng and Cai, 2012). Mitochondrial dysfunction and axonal 
transport defects have been shown to occur well before the axonal degeneration 
phenotype in disease models (Ferreirinha et al., 2004; Shidara and Hollenbeck, 2010). A 
HSP mouse model that lacks paraplegin, a mitochondrial AAA ATPase protein, shows 
disrupted mitochondrial structure, and impaired axonal transport, both appearing well 
before the gross phenotype of distal axonal degeneration of spinal and peripheral nerves 
(Ferreirinha et al., 2004). Recent studies on a Friedreich Ataxia Drosophila model 
deficient in frataxin, an Fe-S cluster chaperone of respiratory chain complexes, 
demonstrated the mitochondrial dysfunction, and retrograde transport defects, all 
occuring well before distal axonopathy (Shidara and Hollenbeck, 2010). These reports 
clearly suggest that mitochondrial axonal transport defects are related to dying-back 
neuropathy.  
1.1.6 Mitochondrial Fusion - Fission  
Mitochondria are highly dynamic organelles which undergo continuous cycles of 
fusion and fission to maintain their function and morphology. Mitochondrial fusion 
involves the sequential fusion of both the outer and inner membranes of two adjacent 
mitochondria. Fusion of outer mitochondrial membranes is carried out by Mitofusin 
proteins (Mfn1 and Mfn2 in mammals) present on adjacent mitochondria, while 
subsequent to this, the fusion of inner membranes is mediated by optic atrophy protein 1 
(Opa1) (Figure 1.2). Complete fusion results in the mixing of the mitochondrial matrix 
contents. Disruption of mitochondrial fusion by the deletion of either mitofusins or Opa1 
in mouse embryonic fibroblasts (MEFs) results in a heterogenous population of 
mitochondria with varied bioenergetic status, and the majority of mitochondria lose 
mtDNA nucleoids due to lack of re-distribution in the absence of fusion (Chen et al., 
2005; Chen et al., 2007). Consistent with this, mitochondria show a reduction in 
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respiratory activities and low oxygen consumption rates in the absence of fusion (Chen 
et al., 2005; Chen et al., 2007). These studies clearly suggest that mitochondrial fusion 
helps in the maintenance of mitochondrial function via the mixing and re-distribution of 
mitochondrial contents. Because mitochondria are the major source of ROS, mtDNA is 
particularly prone to ROS damage, and accumulates somatic mutations. Mutations in 
mtDNA can cause the loss of mitochondrial ETC protein subunits or affect their activity, 
resulting in mitochondrial dysfunction. In such conditions, fusion of mitochondria having 
mutations in different genes has been shown to restore respiratory function in HeLa cells 
by functional complementation (Ono et al., 2001; Westermann, 2010; Westermann 
2012). Thus mitochondrial fusion plays a crucial role in the maintenance of mitochondrial 
function via complementation of gene products. 
Mitochondrial fission is carried out by GTPases - dynamin-related protein 1 
(Drp1) and mitochondrial fission protein (Fis1). Fis1 is present on the surface of outer 
mitochondrial membrane and recruits cytosolic Drp1 onto the mitochondrial membrane 
at the site of impending scission (Figure 1.2). Drp1 assembles in the form of a spiral 
around the mitochondrial constriction site and divides the organelle into two, which 
requires GTP hydrolysis (Westermann, 2010; Mishra and Chan, 2014). Disruption of 
fission results in mitochondrial dysfunction, oxidative damage, and reduced mitophagy in 
mammalian cells (Parone et al., 2008; Twig et al., 2008a), suggesting that fission helps 
to maintain mitochondrial function, probably by segregating damaged mitochondria for 
degradation (Chen and Chan, 2009). 
 
Figure 1.2 Proteins involved in mitochondrial fusion and fission. A) Mitofusin (Mfn) 
proteins present on adjacent mitochondria mediate the fusion of mitochondrial outer 
membrane. Fusion of inner membrane is carried out by optic atrophy protein Opa1. B) 
Mitochondrial fission protein Fis1 on the mitochondrial outer membrane recruits the 
cytosolic dynamin-related protein Drp1 to the scission site. Drp1 forms as a spiral 
structure and constricts the mitochondrial membrane resulting in organelle fission. 
(Figure is adapted and modified from Chen and Chan, 2005). 
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Steady-state mitochondrial morphology depends on the balance between fusion 
and fission rates in cells. Genetic disruption of either fusion or fission proteins has been 
shown to dramatically alter the mitochondrial morphology in mammalian cells (Detmer 
and Chan, 2007; Amiri and Hollenbeck, 2008). Impaired fission by the depletion of Drp1 
has resulted in highly interconnected network like morphology in COS-7 cells (Smirnova 
et al., 2001). On the other hand, impaired fusion by the knockdown of Mfns has caused 
the formation of small fragmented mitochondria in MEFs (Chen et al., 2003). In addition, 
mitochondrial morphology has been shown to change in response to the altered 
physiological state of the cell. When fibroblasts are deprived of nutrients, mitochondria 
become elongated and interconnected forming a network mainly due to the down-
regulation of Drp1 activity. Elongated mitochondrial morphology has been shown to 
correlate with high respiratory capacity, which supplies energy for cell survival during 
starvation (Gomes et al., 2011; Rambold et al., 2011). Moreover, elongated mitochondria 
are not easily engulfed by autophagic vesicles, and thus are spared from starvation-
induced autophagy (Gomes et al., 2011; Rambold et al., 2011). 
Mitochondrial fission-fusion processes have been proposed to play a crucial role 
in mitochondrial quality control, based on recent studies involving the long term tracking 
of single mitochondria in pancreatic INS1 and β-cells (Twig et al., 2008a). Mitochondrial 
fission-fusion processes occur continuously, with each fusion event followed by a fission 
event. Very often, fission generates two functionally distinct daughter mitochondria: one 
with a hyperpolarized and the other with a depolarized inner membrane. The 
hyperpolarized mitochondrion has a high probability of undergoing fusion with healthy, 
functional mitochondrial network. However the depolarized mitochondrion is prevented 
from undergoing fusion due to the downregulation of fusion protein Opa1 activity. Thus it 
has been proposed that fission followed by selective fusion helps to segregate damaged 
mitochondria for mitophagic degradation (Twig et al., 2008a; Twig et al., 2008b).  
Given the crucial role of mitochondrial fusion-fission processes in the 
maintenance of mitochondrial function and in quality control, any defects in mitochondrial 
dynamics will affect neuronal function and survival. This is very evident as mutations in 
Mfn2 and Opa1 have been shown to cause human neurodegenerative diseases, 
including CMT2A and DOA, respectively (Chan, 2006). Disruption of mitochondrial 
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fusion due to loss of Mfn2 function in mouse cerebellum has caused mitochondrial 
structural defects including disintegrated cristae, and ETC defects (Chen et al., 2007). 
This indicates the role of mitochondrial fusion in the maintenance of mitochondrial 
function via content mixing and re-distribution of mitochondrial contents. Deletion of Drp1 
has shown abnormal mitochondrial morphology and respiratory defects in mouse 
cerebellar purkinje cells (PC) (Kageyama et al., 2012). These defects become 
progressively more severe with age, and appeared before PC neurodegeneration. 
Moreover, accumulation of LC3 mitophagy marker around mitochondria indicates the 
impaired degradation of mitochondria. Interestingly, treatment with antioxidants has 
restored the mitochondrial defects and PC neurodegeneration in the absence of Drp1. 
These results suggest that mitochondrial fission acts in mitochondrial quality control via 
the segregation of the damaged mitochondria, thereby protecting neuronal cells from the 
accumulation of oxidative damage (Kageyama et al., 2012). Deletion of Drp1 fission 
protein in mouse neuronal cultures produces a significant reduction in mitochondrial 
entry into neurites, implying the role of fission in generating small transportable 
mitochondria for their proper distribution in neurons (Ishihara et al., 2009). Absence of 
Drp1 in the Drosophila nervous system gives rise to the elongated mitochondria in the 
proximal and distal axons, suggesting that mitochondrial fission occurs in axons in vivo 
(Verstreken et al., 2005). In cultured vertebrate peripheral neurons, overexpression of 
the fusion protein Mfn1 or downregulation of the fission protein Drp1 resulted in an 
elongated mitochondrial morphology in distal axons. This clearly indicates that the 
mitochondrial fusion-fission processes indeed occur in axons, not just in the cell body 
(Amiri and Hollenbeck, 2008). However, it is worth noting that the rate of fusion-fission is 
~6 fold lower in axons than in the somatic compartment (Cagalinec et al., 2013).  
1.1.7 The Intricate interrelationship of Mitochondrial Metabolic Function, Transport, and 
Fission - Fusion  
Axonal transport depends heavily on mitochondrial aerobic ATP production, as 
the cargo-delivering motor proteins require ATP for their activity. A variety of disruptions 
of mitochondrial metabolism have been shown to affect mitochondrial transport. In 
cultured vertebrate neurons, treatment with mitochondrial uncouplers or inhibition of ATP 
synthase or the electron transport chain diminished mitochondrial transport (Hollenbeck 
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et al., 1985; Rintoul et al., 2003; Miller and Sheetz, 2004), while complex III inhibition 
transiently increased retrograde transport (Miller and Sheetz, 2004). These studies 
indicate that mitochondrial metabolic function and axonal transport are related. 
Numerous studies indicate that the mitochondrial fusion-fission processes and 
axonal transport are inter-related. Disruption of the mitochondrial fission protein Drp1 in 
the Drosophila nervous system has resulted in sparse distribution of mitochondria at 
neuromuscular junctions (NMJs) implying defects in mitochondrial transport (Verstreken 
et al., 2005). This transport defect is attributed to the disruption of Drp1-dependent 
fission that normally generates mitochondria amenable for axonal transport. The 
mitochondrial fusion protein Mfn2 has been shown to mediate motility in cultured dorsal 
root ganglion (DRG) neurons (Baloh et al., 2007), via its interaction with Miro and Milton, 
the kinesin-linker proteins (Misko et al., 2010). On the other hand, overexpression of 
Miro increases mitochondrial lengths in cultured rat cortical neurons (Saotome et al., 
2008) and in Drosophila motor axons in vivo (Russo et al., 2009). Knock-down of Miro 
has decreased mitochondrial lengths in cultured rat cortical neurons (Cagalinec et al., 
2013). In addition, enhanced mitochondrial motility by Myosin-V knock-down has 
resulted in elongated mitochondria in axons of Drosophila cultured neurons (Pathak et 
al., 2010). Recently, detailed analyses of mitochondrial fusion-fission in cultured neurons 
suggest that the rate of fusion events increases with enhanced motility, whereas fission 
is triggered by an increased mitochondrial length, thereby help maintain the 
mitochondrial length in axons (Cagalinec et al., 2013).  
 Thus, although the mechanisms remain unclear, it is apparent that there is a 
complex interplay among mitochondrial function, axonal transport, and fusion-fission 
processes.  
1.1.8 Mitochondrial Turnover by Mitophagy 
 Autophagy is a catabolic process that is triggered to provide essential molecular 
building blocks when cells are deprived of nutrients during starvation. During autophagy, 
cytosolic contents including a variety of organelles, and protein aggregates, are engulfed 
into double membranous autophagosomes. These autophagosomes then fuse with 
lysosomes to deliver the contents for enzymatic digestion and recycling. Unlike this non-
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selective autophagy that occurs during starvation, selective autophagy occurs under 
nutrient rich conditions to eliminate and recycle damaged or excess organelles in cells. 
Several cargoes including endoplasmic reticulum (reticulophagy), peroxisomes 
(pexophagy), foreign pathogens (xenophagy), mitochondria (mitophagy), are known to 
be specifically targeted and eliminated by selective autophagy process (Kim et al., 2007; 
Goldman et al., 2010).  
 So far, ~31 essential autophagy-related (ATG) genes have been identified from 
yeast genetic screens (Mizushima, 2007). The key ATG genes, essential for all types of 
autophagy including the formation and maturation of autophagosomes, are evolutionarily 
conserved from yeast to mammals (Kim et al., 2007; Mizushima, 2007; Suzuki and 
Ohsumi, 2007). Some of the core molecular machinery involved in general autophagy 
has been shown to be required for mitophagy. Deletion of autophagy-related genes 
(ATG1, ATG6, ATG8, and ATG12) results in the accumulation of mitochondria in yeast 
(Zhang et al., 2007). Moreover, when these ATG deficient yeast strains are forced to 
depend on mitochondrial oxidative phosphorylation by growing them on non-fermentable 
medium, several mitochondrial functional defects become manifest, including low IMP, 
low ETC activity, and high levels of ROS (Zhang et al., 2007). This indicates a key role 
for autophagy in mitochondrial quality control. In addition, disruption of autophagy by 
Atg7 deletion in mice compromises mitochondrial functions, producing respiratory 
defects and high ROS levels in skeletal muscle (Wu et al., 2009), and suggesting a role 
for Atg7 in mitochondrial maintenance. Atg32, an outer mitochondrial membrane protein, 
identified from yeast genome-wide screening, has been shown to act as a mitophagy 
receptor for selective degradation of mitochondria (Ishihara and Mizushima, 2009; Kanki 
et al., 2009; Okamoto et al., 2009). Atg32 possesses two motifs to interact specifically 
with Atg11 and Atg8, which then mediate the formation of autophagosomal isolation 
membrane around mitochondria for degradation (Liu et al., 2014; Wei et al., 2015). 
Although mammalian homologues of Atg32 are not identified yet, there is abundant 
evidence for the occurrence of mitophagy in mammalian cells. For example, in cultured 
rat hepatocytes, GFP-LC3 (a mammalian homologue of Atg8) autophagic vesicles are 
formed selectively around depolarized mitochondria after photodamage (Kim et al., 
2007; Kim and Lemasters, 2011). This indicates that damaged mitochondria are 
selectively targeted for mitophagy.  
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 Mitophagy has also been shown to occur during specific developmental 
processes, including erythrocyte maturation and oocyte fertilization. During oocyte 
fertilization, sperm mitochondria are specifically targeted and eliminated by mitophagy 
(Shitara et al., 2000; Al Rawi et al., 2011; Sato and Sato, 2011). During the maturation of 
erythroid cells, the Bcl-2 related protein Nix (BNIP3L), an outer mitochondrial membrane 
protein, has been shown to act as a mitophagy receptor for the selective elimination of 
mitochondria. Loss of Nix function inhibits the clearance of mitochondria in reticulocytes 
(Schweers et al., 2007; Sandoval et al., 2008). In particular, Nix has been shown to 
induce mitochondrial depolarization and specifically incorporate the mitochondria into 
autophagosomes for mitophagy (Schweers et al., 2007; Sandoval et al., 2008). In 
addition, Nix has been shown to promote autophagosome formation by recruiting 
LC3/GABARAP protein onto depolarized mitochondria (Novak et al., 2010). All these 
studies on mitophagy indicate that loss of mitochondrial membrane potential probably 
acts as a signal for selective elimination of mitochondria.  
1.2 PINK1 - Parkin Pathway in Mitochondrial Turnover 
In mammalian cells, PTEN-induced putative kinase 1 (PINK1) and the E3 
ubiquitin ligase parkin have been characterized to selectively target depolarized 
mitochondria for turnover. Genes encoding parkin, a cytosolic ubiquitin ligase, and 
PINK1, a mitochondrial kinase, are originally identified to be associated with Parkinson’s 
disease (PD), and their mutations have been shown to cause the autosomal recessive 
form of familial PD (Kitada et al., 1998; Valente et al., 2004). PD is a common 
neurodegenerative disease characterized by the loss of dopaminergic (DA) neurons in 
the substantia pars compacta. Loss of mitochondrial complex I activity has been 
observed in the nigral neurons of human PD patients, indicating the link between PD and 
mitochondrial dysfunction (Mounsey and Teismann, 2011).   
1.2.1 Association of PINK1/Parkin with Mitochondrial Dysfunction 
Loss of parkin function in Drosophila has been shown to cause apoptotic muscle 
degeneration and spermatid individualization defects, resulting in flight and climbing 
disabilities and male sterility in these flies. In addition, these tissue-specific phenotypes 
are associated with abnormal mitochondrial structure (Greene et al., 2003). In parkin 
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mutants, ultrastructural observations of mitochondria in indirect flight muscle during 
development have shown swollen mitochondria with disintegrated cristae before the 
muscle degeneration phenotype occurs. This suggests that mitochondrial disruption 
underlies the cellular pathology observed in parkin mutants (Greene et al., 2003). As in 
parkin mutants, lack of PINK1 function in Drosophila has also shown very similar tissue-
specific phenotypes associated with abnormal mitochondrial morphology (Clark et al., 
2006; Park et al., 2006). Lack of both PINK1 and parkin also produces similar defects 
with no further severity, suggesting that PINK1 and parkin are acting in a linear pathway. 
Further genetic epistatic analyses have indicated that parkin is acting downstream of 
PINK1 in this pathway, as parkin overexpression rescues the phenotypes in PINK1 
mutants, but not vice-versa (Clark et al., 2006; Park et al., 2006). Loss of PINK1 function 
in mice has shown mitochondrial functional defects in the striatum, suggesting the role of 
PINK1 in maintaining mitochondrial function (Gautier et al., 2008). In addition, absence 
of PINK1 causes an increased susceptibility of mitochondria to oxidative stress, 
suggesting that PINK1 protects mitochondria against stress (Gautier et al., 2008). All 
these studies in vivo clearly indicate the role of PINK1 and parkin in the maintenance of 
mitochondrial functional integrity.  
1.2.2 Model of PINK1/Parkin in Mitochondrial Turnover 
     PINK1, a mitochondrial kinase is present at very low levels on functional 
mitochondria due to its constitutive degradation that is dependent on mitochondrial inner 
membrane potential (Jin et al., 2010; Matsuda et al., 2010). However, PINK1 
degradation is inhibited on depolarized mitochondria, and under these conditions the 
protein accumulates and recruits cytosolic parkin to depolarized mitochondria (Matsuda 
et al., 2010; Narendra et al., 2010; Vives-Bauza et al., 2010). Cytosolic parkin, an E3 
ubiquitin ligase, has been found to translocate to depolarized mitochondria in cultured 
cells treated with mitochondrial uncouplers, and only in the presence of PINK1 
(Narendra et al., 2008; Vives-Bauza et al., 2010). This suggests that the loss of 
mitochondrial membrane potential serves as a signal and PINK1 is required for parkin 
localization to mitochondria. GFP-LC3-tagged autophagic vesicles have formed around 
the depolarized mitochondria in the presence of parkin, suggesting the role of parkin in 
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targeting depolarized mitochondria for mitophagy (Narendra et al., 2008; Vives-Bauza et 
al., 2010).  
Once targeted to damaged mitochondria, parkin has been proposed to 
ubiquitinate the mitochondrial outer membrane proteins, which then mediate the 
recruitment of ubiquitin-binding adaptor proteins including p62 and optineurin (Wei et al., 
2015). It has been shown that p62 is required for mitophagy (Geisler et al., 2010), 
although other studies (Narendra et al., 2010; Okatsu et al., 2010) indicate that it has a 
role in perinuclear clustering of mitochondria but not in mitophagy. Recently, optineurin 
has been shown to mediate mitophagy process in the absence of p62 (Wong and 
Holzbaur, 2014). In addition, optineurin has been shown to be recruited by parkin to the 
damaged mitochondria prior to the formation of LC3 autophagic vesicles indicating the 
role of optineurin as a receptor for mitophagy (Wong and Holzbaur, 2014).  
All these reports support the role of PINK1 and parkin in tagging depolarized 
mitochondria for mitophagy (Figure 1.3).  
 
Figure 1.3 Model of PINK1 and Parkin in mitochondrial turnover. a) PINK1 is 
degraded on healthy mitochondria. PINK1 retained on depolarized mitochondria (b), 
recruits cytosolic parkin (c) that serves as a signal for mitochondrial turnover. Parkin 
ubiquitinates mitochondrial outer membrane proteins (OMMs) which then recruit 
optineurin as a mitophagy receptor, thereby tagging mitochondria for degradation (d). 
(Figure is adapted and modified from Abeliovich, 2010; Fiskin and Dikic, 2013; Wei et 
al., 2015).  
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It is important to note that this model of PINK1/parkin in the selective turnover of 
depolarized mitochondria has been proposed mainly based on studies in cell cultures 
broadly treated with mitochondrial uncouplers. However, it is not known if PINK1-Parkin 
pathway can selectively target depolarized mitochondria for turnover under normal 
physiological conditions in vivo and in the nervous system.  
1.2.3 Model of PINK1/Parkin in the Segregation of Depolarized Mitochondria  
PINK1 and parkin have been shown to regulate mitochondrial morphology by 
interacting with the mitochondrial fission and fusion proteins. Overexpression of fission 
protein Drp1 or knockdown of fusion protein Opa1 has rescued the mitochondrial 
structural defects in muscle tissue of Drosophila PINK1/parkin mutants. This implies that 
PINK1/Parkin pathway regulates mitochondrial morphology either by promoting fission or 
inhibiting fusion (Poole et al., 2008). Later studies have demonstrated the presence of 
higher levels of fusion protein Mfn2, but not fission protein Drp1 in PINK1 and parkin 
mutants suggesting that PINK1/Parkin pathway selectively mediates Mfn2 degradation 
(Poole et al., 2010; Ziviani et al., 2010). Consistently, PINK1 and parkin have been 
shown to cause Mfn1/2 degradation in human neuroblastoma cells on treatment with 
mitochondrial uncouplers (Gegg et al., 2010). Thus, PINK1/Parkin pathway has been 
proposed to have a role in the segregation of depolarized mitochondria by inhibiting their 
fusion with healthy mitochondria (Poole et al., 2010). These fusion-incompetent 
mitochondria, however, can undergo mitochondrial fission by Drp1 to generate small 
fragmented mitochondria that can be easily engulfed by autophagic vesicles for turnover 
(Poole et al., 2010). Recent studies in cultured cortical neurons treated with 
mitochondrial depolarizing agents have shown that parkin translocated onto depolarized 
mitochondria causes an increase in their retrograde flux for turnover in cell body (Cai et 
al., 2012). Although mitochondrial turnover is often presumed to occur in the somatic 
compartment, evidence from cultured neurons indicates that it can also occur in axons 
(Maday et al., 2012). In addition to the role in mitochondrial turnover, PINK1/Parkin 
pathway has been proposed to inhibit the axonal transport of mitochondria via the 




However, the role of PINK1/Parkin pathway in mitochondrial turnover is not 
known under normal physiological conditions in nervous system in vivo. In addition, we 
understand very little about the changes that occur in the mitochondrial life cycle when 
the mitochondrial turnover is disrupted particularly in neurons. To address the events of 
mitochondrial life cycle that are presumed to be compartmentalized spatio-temporally in 
neurons, I have chosen the Drosophila larval nervous system. This serves as an ideal 
model in that it allows to perform live cell imaging at different regions of neurons 
including the cell body, axon, and neuromuscular junctions (NMJs) (Shidara and 
Hollenbeck, 2010; Devireddy et al., 2014). In addition, Drosophila is genetically tractable 
and has well-established genetic procedures for generating gene deletion mutants (St 
Johnston, 2013), and for manipulating gene expression via RNAi knockdown or 
overexpression in specific tissues using UAS-Gal4 system (Brand and Perrimon, 1993).  
Based on the proposed roles of PINK1 in mitochondrial quality control, I 
hypothesized that the loss of PINK1 function will cause accumulation of senescent 
mitochondria in the axon, defects in mitochondrial transport, and a significant shift in the 
mitochondrial fusion-fission steady state. Here, I tested these hypotheses in vivo, using 
quantitative observations of mitochondria in Drosophila nervous system with deletion 
and overexpression of genes in the PINK1/Parkin pathway. Although I found diminished 
mitochondrial membrane potential in PINK1 deletion, I did not observe the predicted 
increase in mitochondrial density or length in axons. In addition, loss of PINK1 caused 
more specific, essentially balanced defects in mitochondrial transport, without altering 
the balance between stationary and moving mitochondria. These results circumscribe 
the possible mechanisms of PINK1 action in the mitochondrial life cycle, and also raise 
the possibility that mitochondrial turnover events that occur in cultured embryonic 













Scissors (Fine Science Tools- FST No. 15000-00 straight), two pairs of forceps 
(FST, Dumont #5 Dumonstar No. 11295-00), Minutien insect pins (FST No. 26002-10), 
glass slides (Rite-On microslides Cat no. 3050, size 25mm X 75mm) and coverslips (24 
X 40 mm No.1, VWR Cat #16004-306), Sylgard plate (Sylgard 182 Silicone Elastomer 
Kit), double sided permanent tape (Scotch Cat # 137DM-2 or 3M with 0.5 inch 
thickness), VALAP (Vaseline, Lanolin and Paraffin wax in equal parts) heated to 750C, 
paint brush with small brush head. 
2.1.1 Chemicals: NaCl (Mallinckrodt chemicals; Cat No: 7581), KCl (Sigma; Cat No: P-
9541), MgCl2·6H2O (Mallinckrodt chemicals; Cat No: 5958-04), NaHCO3 (Sigma; Cat 
No: S-6014), Isothionic acid sodium salt (Sigma; Cat No: 220078), BES (Sigma; Cat No: 
B4554), Trehalose dehydrate (Sigma; Cat No: T9531), L-Alanine (Sigma; Cat No: 
A7469), L-Arginine monohydrochloride (Sigma; Cat No: A6969), Glycine (Sigma; Cat 
No: G-7126), L-Histidine (Sigma; Cat No: H6034), L-Methionine (Sigma; Cat No: M-
2893), L-Proline (Sigma; Cat No: P5607), L-Serine (Sigma; Cat No: S4311), L-Threonine 
(Sigma; Cat No:T8441), L-Tyrosine (Sigma; Cat No: T8566), L-Valine (Sigma; Cat No: 
V0513), CaCl2 Dihydrate (Sigma; Cat No: C-3306), L-Glutamate monosodium salt 
hydrate (Sigma; Cat No: G5889), tetramethylrhodamine methyl ester (TMRM, Life 
Technologies, Molecular Probes; Cat No: T668), Dimethyl sulfoxide (DMSO-HybriMax; 
sterile filtered 5X10ml vials; Sigma; Cat No: D2650). 
2.1.2 Hemolymph-like solution (HL6 buffer): 
Composition of HL6 Buffer: 23.7mM NaCl, 24.8mM KCl, 15mM MgCl2·6H2O, 10mM 
NaHCO3, 20mM Isothionic acid (Na+), 5mM BES, 80mM Trehalose, 5.7mM L-Alanine, 
2mM L-Arginine HCl, 14.5mM Glycine, 11mM L-Histidine, 1.7mM L-Methionine, 13mM 
20 
 
L-Proline, 2.3mM L-Serine, 2.5mM L-Threoine, 1.4mM L-Tyrosine, 1mM L-Valine, 
0.6mM CaCl2 Dihydrate and  4mM L-Glutamate monosodium salt hydrate (Macleod et 
al., 2002, Louie et al., 2008).  
HL6 buffer stock (1.25X) was prepared in sterile distilled water by dissolving all 
the above components expect 4mM glutamate. The pH of the buffer was adjusted to 7.2, 
followed by filter sterilization. This buffer stock and 1M glutamate stock were stored for 
about 6-8 months at 4°C.  
2.2 Drosophila Maintenance and Genetics 
2.2.1 Maintenance of Drosophila Stocks: 
Drosophila stocks were grown in vials with a standard yeast corn meal agar medium and 
maintained in a fly room set to 250C temperature, 50-55% humidity, and 12 hour light-
dark cycles. Genotypes of the fly stocks are as follows:  
w1118 
D42-Gal4>UAS-mitoGFP (III)  
PINK1RV (I) 
PINK1B9/FM7GFP (I); D42-Gal4>UAS-mitoGFP/TM6C (III) 
PINK15/FM7GFP (I); D42-Gal4>UAS-mitoGFP/TM6C (III) 
PINK19/FM7GFP (I); D42-Gal4>UAS-mitoGFP/TM6C (III) 
Casper Pink1-Myc (III) (Referred as P(Pink1)) 
UAS-PINK1/CyOGFP (II); TM6B/MKRS (III) 
UAS-Parkin/CyO (II) 
UAS-NDI1 (II) 
2.2.2 Crosses Set for Obtaining Larvae with Specific Genotypes: The above stocks were 




Table 2.1: Genotype Representation of Flies Used in Crosses 
Genotype 
representation 
in text and 
figures 
Crosses set up between Genotype of male 
larvae used in 
experiments Female virgins Males 



































































































































2.2.3 Selection of Male Drosophila Larvae for Experiments: 
The PINK1 gene is present on the X chromosome in Drosophila and all PINK1 deletion 
mutants (PINK1B9, PINK15, and PINK19) are sterile both as homozygous females and 
hemizygous males. However, PINK1 mutant stocks are maintained using a balancer 
chromosome and it is possible to collect mutant males. Thus, male larvae were chosen 
for all the genotypes except for PINK15/+. 
In Drosophila larvae, gonads are present in the fifth abdominal segment of the 
posterior part of the body. The size of gonad is larger in males than females, which 
appears as a clear round halo structure in males compared to small spot like structure in 
females. Thus male larvae are identified easily by observing the halo structure through 





2.3 Drosophila Larval Prep for Live Cell Confocal Imaging (Larval Prep) 
Prior to larval dissection, 1X HL6 buffer with 4mM glutamate was constituted 
from HL6 buffer stock and 1M glutamate stock, and brought to room temperature before 
applying to larvae. The glass slide, which serves as an imaging chamber, was prepared 
by attaching two strips of double sided tape cut lengthwise as spacers, so as to match 
the length of the coverslip (Devireddy et al., 2014).  
2.3.1 Dissection procedure:  
The whole procedure of dissection is completed in five minutes. First, a crawling late 
third instar larva is washed in distilled water with a paint brush to remove any food 
particles, and is then placed on a slygard plate with the dorsal surface facing upwards, 
viewing two long tracheal tubes running along the length of the larval body. The larva is 
then pinned with insect pins, first at the posterior end followed by the anterior end 
(Figure 2.1 Aa). A small incision is made at the posterior end of the larva with fine 
scissors and then cut longitudinally from posterior to anterior end by just holding the 
larval body wall (Figure 2.1 Ab,c). Immediately, 400µl of HL6 buffer is added to the larva 
and internal tissues such as tracheal tubes, intestines, fat bodies and salivary glands are 
gently removed using forceps, leaving the ventral ganglion and segmental nerves intact. 
The buffer with separated internal tissues is quickly removed with a kimwipe and 
replaced with fresh buffer, to clearly visualize the brain lobes and segmental nerves 
attached to the larval body wall (Figure 2.1 Ad). In order to make the body wall flat, small 
lateral cuts perpendicular to the longitudinal cut are made on both sides at posterior and 
anterior ends (Figure 2.1 Ae,f). The pins are then removed first at the anterior end by 
gently holding the mouth hooks with forceps, and then at the posterior end (Figure 2.1 
Ag).  
2.3.2 Preparation of Dissected Larva for Imaging: 
After removing the insect pins, the dissected larva is moved onto the glass slide with 
double sided tape, by just holding the spiracles at the posterior end. While moving the 
larva onto glass slide, care must be taken to transfer only a few microliters (µl) of buffer 
along with larva, just enough that the larval body wall flaps can be opened with ease, 
and this also helps the larval preparation not to dry out until the next step. Lateral body 
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wall flaps are opened starting from the posterior to the anterior end (Figure 2.1 Ah) and 
the ventral ganglion is made to stretch out by holding the mouth hooks. A coverslip is 
then carefully placed on the larval prep and ~150µl HL6 buffer is added from the 
posterior end towards ventral ganglion region and sealed with VALAP on both sides to 
form an imaging chamber. While adding the HL6 buffer, the dissected larva stretches out 
longitudinally revealing all segmental nerves ending in corresponding abdominal 
segments A1-A8 (Figure 2.1 Ai, j).  
 
Figure 2.1 Procedural steps of Drosophila larval dissection. a) Larva is immobilized 
on slygard plate by inserting insect pins at the anterior (A) and posterior (P) ends. b) A 
small opening is made at the posterior end using the fine scissors. c) From this small 
opening, larval body wall is cut longitudinally towards the anterior end. d) After the 
removal of internal tissues, buffer is added to reveal the ventral ganglion and segmental 
nerves. e, f) Small lateral cuts are made at the posterior end (e) followed by anterior end 
(f) to open up the folded larval body wall. g) This image represents the properly 
dissected larva after the removal of insect pins. h) The dissected larva is transferred 
onto glass slide and folded body wall is opened gently beginning at the posterior end as 
indicated by arrow and then at the anterior end. i, j) Representative bright-field image (i) 
and fluorescent image (j) of the dissected larva with completely stretched out segmental 
nerves (SNs) suitable for imaging at defined positions (Figure is adapted and modified 







A Drosophila line expressing mitochondrial targeted GFP (mitoGFP) specifically in motor 
neurons was used in this study (Figure 2.2).  
 
Figure 2.2: MitoGFP expression in Drosophila motor neurons. a) Image showing the 
Drosophila larval nervous system (a) expressing mitoGFP in motor neurons with cell 
bodies (CBs) in ventral ganglion (VG) (b), segmental nerve (SN) axons (c), and 
neuromuscular junctions (NMJs) (d). (Figure is adapted and modified from Devireddy et 
al., 2014). 
2.4 Analysis of Mitochondrial Motility in Segmental Nerves (SNs) 
2.4.1 Acquisition of Time Lapse Images Using Confocal Microscopy 
Time lapse images of mitoGFP were acquired in the middle (A4) abdominal region of the 
longest SN in the larva (Figure 2.2). All imaging was performed with a Nikon C-1 laser 
scanning confocal microscope (Nikon Eclipse 90i) using EZ-C1 software. Time lapse 
images were acquired using a 60X oil-immersion objective and 2.5X zoom at 1024 pixel 
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resolution and at 1frame/second for five minutes with a 488nm laser (5%; 150mW laser 
power) and a 30μm pinhole. The whole imaging process was then completed within 25 
minutes to ensure normal physiological conditions of the live nervous system.  
2.4.2 Tracking of Anterograde and Retrograde Mitochondria Using ImageJ 
In Drosophila SNs, anterograde and retrograde mitochondria can be easily distinguished 
because they move preferentially in the primary direction for the majority of the time, with 
only a small fraction of time spent moving in reverse runs or in pauses. In addition, 
stationary mitochondria remain at the same position during the entire imaging period in 
Drosophila larval SNs. All three types of mitochondria can be seen in kymographs 
prepared from the time lapse images, in Nikon NIS-Elements software by using the 
“create kymograph by line” option in Image/ND processing. The numbers of 
mitochondria that cross the line drawn in the center of the image per unit time were 
counted using the “cell counter” plugin in ImageJ. This number represents the 
mitochondrial flux per unit time.   
For quantifying the other mitochondrial motility parameters such as duty cycles 
(% time mitochondria spend in their primary direction runs, reverse runs, and pauses), 
and run velocities, individual mitochondria were tracked using the manual tracking plugin 
of ImageJ (Pilling et al., 2006, Shidara and Hollenbeck, 2010, Devireddy et al., 2014). To 
correct for any larval movements causing drift, stationary mitochondria were tracked for 
the entire length of the movie and x-y coordinates were saved for all frames. A minimum 
number of five anterograde and five retrograde mitochondria were tracked for ≥ 60 
seconds and corrected for drift using x-y coordinates of stationary mitochondrion, 
corresponding to time frames of tracked moving mitochondria. The x-y coordinates of 
tracked mitochondria were saved into an excel sheet and the distance moved by 
mitochondria from frame to frame was tabulated.  
Criteria for mitochondrial motility analysis: 
a) Movements with average velocities >0.08 µm/sec or <-0.08 µm/sec for at least 
three consecutive frames were selected as anterograde and retrograde runs 
respectively. A run could be preceded and ended by pauses or by reverse runs 
(1 pixel = 0.08 µm, a minimum measurable distance). 
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b) Periods with average velocities between 0.08 µm/sec and -0.08 µm/sec for at 
least two consecutive frames were considered as pauses. 
After determining the runs and pauses, the run velocities and duty cycles were 
quantified. The velocity of a mitochondrion was determined by taking the average of all 
run velocities for that particular mitochondrion during the observation period. Duty cycles 
were calculated based on the percentage of time mitochondria spent moving in the 
primary direction, reverse runs and in pauses.  
2.4.3 Determination of Stationary, Anterograde, Retrograde and Oscillatory Mitochondria 
To quantify the percentage of moving mitochondria in SNs, time lapse images were 
captured at 1 frame / 2 seconds for two minutes (same imaging settings as above). 
Here, images were acquired at 2 second time interval to allow for 2 frame kalman 
averaging, to increase the signal to noise ratio. Mitochondria present in the first image of 
the time lapse sequence were only considered when counting the stationary and moving 
mitochondria, due to the varied number of moving mitochondria entering the field of view 
over time. Mitochondria were categorized as anterograde, retrograde, stationary 
(remaining at the same position during the imaging period), or oscillating (moving back 
and forth with an amplitude of ≤ 5 μm without significant net displacement). These 
different categories of mitochondria were counted using the “cell counter” plugin in 
ImageJ and the cell counters were saved with numbers indicating the different 
categories, for measuring mitochondrial lengths (Refer Section 2.6.1). 
2.4.4 Determination of Mitochondrial Density in Motor Axons 
The first image of the above time lapse sequence acquired at 1 frame / 2 seconds was 
selected to determine the mitochondrial density in motor axons. The image was 
thresholded, and then binarized using ImageJ. On these binarized images, the number 
of mitochondrial pixels per length of segmental nerve was obtained, to represent 





2.5 Determination of Mitochondrial Inner Membrane Potential (IMP) 
2.5.1 Treatment of Larval Prep with TMRM 
Preparation of TMRM stock and working solutions: 20mM TMRM stock (200µl) was 
prepared by dissolving TMRM powder in sterile filtered DMSO, by vortexing for a minute. 
Then 5µl stock aliquots were made and stored in -800C freezer for use within 6-8 
months. Before performing the TMRM experiment, 20mM stock aliquot was thawed to 
prepare fresh 20µM TMRM (1ml) in DMSO. From this 20µM TMRM, 200nM and 50nM 
TMRM working solutions were prepared in HL6 buffer for treatment of larval prep. The 
dissected larval prep was treated with 200nM TMRM working solution for 30 minutes in a 
glass dish. After 30 minute incubation, larval prep was gently moved without washing, 
onto glass slide and covered with coverslip. Then 50nM TMRM solution is added to the 
larval prep for imaging.  
2.5.2 Image acquisition in thin neurons and neuromuscular junctions 
Thin neurons, adjacent to SNs in middle (A4) abdominal segment of the larva, were 
chosen for imaging. MitoGFP and TMRM imaging in thin axons, was performed with a 
488nm laser (2-4%) and a 561nm laser (1-2%) respectively, using sequential scan 
(Nikon Eclipse 90i). Images of neuromuscular junctions 6/7 (NMJs 6/7) in A4 segment 
were acquired sequentially with 488nm (5%) and 561nm (<5%) lasers for mitoGFP and 
TMRM respectively. 561nm laser power was adjusted to avoid acquiring saturated pixels 
since the images were used for quantification. Both thin neuronal and NMJs 6/7 images 
were acquired using a 60X oil-immersion objective and 2.5X zoom at 512 pixel 
resolution, with the Nikon C-1 laser scanning confocal microscope using EZ-C1 
software. The images were taken within 15 minutes after the slide was prepared for 
imaging. Only NMJs 6/7 were imaged but not SNs and motor neuron cell bodies in 
ventral ganglion as the TMRM dye could not penetrate the glial sheath covering SNs and 
ventral ganglion.  
2.5.3 Quantitative assessment of TMRM fluorescent intensities 
The TMRM images of axons or NMJs were thresholded to isolate the mitochondrial 
pixels. Then the mitochondrial fluorescence intensities (Fm) were measured using 
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“analyze particles” option after selecting for mean gray value option in “analyze/set 
measurements” in ImageJ. Adjacent cytoplasmic fluorescence intensities (Fc) were 
determined using hand drawn regions (0.4-0.5 µm2 area) in the axons, next to 
mitochondria. The ratio of mitochondrial to cytoplasmic fluorescence (Fm/Fc) was used 
as a logarithmic measure of mitochondrial inner membrane potential (IMP or Δψm) in 
axons (Verburg and Hollenbeck, 2008, Shidara and Hollenbeck, 2010). As the 
cytoplasmic regions cannot be clearly defined near NMJs, the mean mitochondrial 
intensities (Fm) quantified from thresholded TMRM images were used to represent the 
IMP or Δψm at NMJs (Shidara and Hollenbeck, 2010).  
2.6 Determination of mitochondrial morphology in motor neurons 
2.6.1 Semi-automated method for mitochondrial length measurements in motor axons 
Time lapse images originally acquired for determining the percent moving mitochondria, 
and their cell counters saved for different categories of mitochondria, were used to 
determine mitochondrial lengths in motor axons. A time lapse image sequence was 
thresholded, binarized and the “feret’s diameter” option was selected in the 
“ImageJ/analyze/set measurements” menu to measure mitochondrial lengths. In 
addition, “watershed” function was used to separate the adjoined stationary mitochondria 
whose edges were not distinct enough, before measuring their lengths.  
2.6.2 Acquisition of z-stack of motor cell body images in ventral ganglion 
Confocal z-stack of motor neuron cell bodies present in ventral ganglion were acquired 
with slice thickness of 0.15µm, using a 488nm (1.8%) laser and 60X oil immersion Nikon 
objective at 2.5X zoom. The stacks were aligned with the “ImageJ/stackreg” plugin 
(Thevenaz et al., 1998), using the middle slice as an anchor, to eliminate the effects of 
drift.  
2.6.3 2D image quantitation of mitochondrial size in motor cell bodies (CBs) 
The size of the large round mitochondria in CBs was measured by selecting the “area” 
option in “ImageJ/analyze/set measurements” menu and then drawing the “polyline 
selection” around mitochondria in a z-slice where they were in sharp focus. Then the cell 
31 
 
bodies with large, round mitochondria of sizes >2µm2 were counted and represented as 
%CBs with large round mitochondria.  
2.6.4 Quantitative 3D image analysis of mitochondrial volume in motor cell bodies 
For determining the mitochondrial volume in CBs, the intensity threshold was adjusted 
manually to include all z-slices of cell bodies. Then, mitochondrial volume was 
determined in CBs using “3D object counter” (Bolte and Cordelieres, 2006) and “3D ROI 
manager” (Ollion et al., 2013) plugins in ImageJ. 3D object counter was used to 
determine if all mitochondrial pixels in cell body were taken for volumetric 
measurements. 3D ROI manager was used to obtain the values of mitochondrial volume 
in the cell bodies after running 3D object counter. 
2.7 Statistical tests 
The number of larvae analyzed in all experiments ranged from 8-11 and was indicated in 
graphs and error bars represent means ± SEM. All statistical analysis was performed 
using “GraphPad Prism 5”. For normally distributed data, one way ANOVA with 
Bonferroni’s post test was used. For non-normally distributed data, the non-parametric 
Kruskal-Wallis test followed by Dunn’s post test was used. All statistical comparisons 
were performed between wild type control vs. PINK1 mutants, and mutants vs. mutants 
with PINK1 genomic level expression or parkin or NDI1 overexpression and were 
indicated in figures or figure legends. For the analysis of mitochondrial length 
distributions, a non-parametric two sample Kolmogorov-Smirnov (KS) test was 














3.1 Mitochondrial Inner Membrane Potential (IMP or ΔΨm) is Diminished in the 
Absence of PINK1 
Loss of PINK1 function has been shown to cause mitochondrial structural defects 
in Drosophila flight muscle (Clark et al., 2006; Park et al., 2006) and functional defects in 
mouse striatum (Gautier et al., 2008). These studies indicate that PINK1 is required for 
the maintenance of mitochondrial integrity. In addition, PINK1 has been shown to 
accumulate on depolarized mitochondria in cell cultures treated with mitochondrial 
uncouplers (Jin et al., 2010; Matsuda et al., 2010; Narendra et al., 2010). Recently, 
PINK1 has been shown to be required for the initiation and the formation of autophagic 
vesicles around damaged mitochondria in cultured neurons treated with mitochondrial 
damaging agents (Ashrafi et al., 2014). Based on these cell culture studies, PINK1 has 
been proposed to have a role in targeting damaged mitochondria for turnover. However, 
the role of PINK1 in mitochondrial turnover is not known in nervous system in vivo under 
normal physiological conditions. Here, I tested the hypothesis that the loss of PINK1 
function will cause the accumulation of senescent mitochondria with diminished 
mitochondrial inner membrane potential (IMP or ΔΨm) by inhibiting turnover in axons.  
To test this hypothesis in vivo, I first assessed the IMP of mitochondria in 
neurons of the intact Drosophila nervous system. To a filleted larval preparation (Pilling 
et al., 2006; Shidara and Hollenbeck, 2010; Devireddy et al., 2014), I applied TMRM, a 
lipophilic cationic fluorescent dye, which partitions between the cytoplasm and the 
mitochondrial matrix based on the magnitude of the IMP (Figure 3.1A,C) (Scaduto and 
Grotyohann, 1999; Verburg and Hollenbeck, 2008). I quantified the ratio of mitochondrial 
to cytoplasmic fluorescence intensities (Fm/Fc), which is related logarithmically to IMP in 
axons (Verburg and Hollenbeck, 2008; Shidara and Hollenbeck, 2010). I observed ~34-
39% reduction in the mean Fm/Fc values in motor axons and ~16-38% decrease in mean 
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Fm values in NMJs of PINK1 mutants (PINK1B9 or PINK15) compared with control, as 
expected (Figure 3.1 B,D). This deficit is partially rescued in NMJs of PINK1 mutants by 
expressing physiological levels of PINK1 from a genomic promoter (Clark et al., 2006) 
(Figure 3.1 B,D) suggesting the role of PINK1 in the maintenance of mitochondrial IMP. 
Because the ubiquitin ligase parkin has been shown to act downstream in the 
PINK1 mitochondrial maintenance pathway (Clark et al., 2006; Park et al., 2006; Poole 
et al., 2008), I also assessed the IMP in PINK1 mutants with parkin overexpression and 
observed significant rescue of IMP in NMJs (Figure 3.1D) and a trend toward rescue in 
PINK15 mutant axons (Figure 3.1B). The restoration of mitochondrial IMP in PINK1 
mutants by parkin overexpression suggests that parkin is acting downstream of PINK1 in 
the maintenance of mitochondrial IMP. In PINK1 mutants, either expressing PINK1 at 
genomic levels or overexpressing parkin rescued the mitochondrial IMP in NMJs, but did 
not in axons, suggesting that the roles of PINK1 and parkin in maintaining mitochondrial 
function differ by region, perhaps in relation to specific bioenergetic demands of different 














Figure 3.1 Neurons of PINK1 mutants show reduced mitochondrial IMP or ΔΨm.  
A, C, TMRM staining of mitochondria (red) reveals the mitochondrial membrane 
potential (ΔΨm), whereas mitoGFP (green) is used to identify mitochondria in axons (A) 
and NMJs (C) of Drosophila larval motor neurons in segmental nerves. Merge (yellow) 
shows the colocalization of mitoGFP- and TMRM-stained mitochondria. These images 
show PINK1RV control larvae. Scale bar, 5µm. Mean Fm/Fc intensity ratios of TMRM in 
axons (B) and mean Fm intensities of TMRM in NMJs (D) are quantified for PINK1RV 
control, PINK1B9, B9;P(Pink1) (genomic rescue), and B9;Parkin OE and for PINK15/+ 
control, PINK15, PINK15;P(Pink1) (genomic rescue), and PINK15;Parkin OE. Compared 
with control larvae, PINK1 mutants show a decrease in mean TMRM intensities, which is 
rescued significantly in NMJs by expression of P(Pink1) and parkin overexpression (OE) 
but improved only modestly in PINK15 mutant axons. Error bars indicate SEM; number of 
larvae is represented on graph bars. Ten to 20 mitochondria were quantified per larva. 






3.2 Mitochondrial axonal transport is impaired in the absence of PINK1 
Because most mitochondrial turnover in neurons is thought to occur in the cell 
body (Cai et al., 2012; Saxton and Hollenbeck, 2012), another prediction of PINK1 
involvement in mitochondrial turnover is that reduced PINK1 function should cause the 
accumulation of senescent mitochondria in the axon, through a reduction in their 
retrograde retrieval and turnover. To examine this, I quantified mitochondrial axonal 
transport in motor axons of middle segmental nerves (A4) of Drosophila larvae by 
tracking individual mitochondria on the time lapse images (Shidara and Hollenbeck, 
2010; Devireddy et al., 2014). 
3.2.1 Loss of PINK1 Function causes a Reduction in both Anterograde and Retrograde 
Mitochondrial Flux 
In axons of segmental nerves, anterograde and retrograde populations of 
mitochondria are clearly distinguished from each other by their preferential movement in 
the dominant direction, with a smaller fraction of their time spent pausing, and a very 
small fraction spent reversing direction; this can be seen in kymographs (Figure 3.2A). A 
detailed quantification of motility (Figure 3.2B,C) showed that mitochondrial flux was 
actually reduced in both the anterograde and retrograde directions in PINK1 mutants 
compared with wild-type, and this was rescued significantly by the expression of PINK1 
by a genomic promoter and partially by overexpression of parkin (Figure 3.2B,C). 
3.2.2 Anterograde Mitochondria show Reduced Duty Cycles and Retrograde 
Mitochondria show Reduced Velocities 
To understand the specific changes in mitochondrial motility behavior that 
caused reduced flux, I quantified the duty cycles and velocities of the moving 
mitochondrial population in axons of wild-type and PINK1 mutants. In wild-type, 
anterograde mitochondria spent ~70% time in anterograde runs, ~29% in pauses, and 
~1% in retrograde runs. In the absence of PINK1, anterograde mitochondria showed a 
significant reduction in percentage of time in anterograde runs (55%–60%), resulting in 
an increase in percentage of time in pauses (38%–44%); however, there was no change 
in retrograde runs (~1%) (Figure 3.2D). These defects in duty cycles of anterograde 
mitochondria were ameliorated by expressing PINK1 with a genomic promoter or by 
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parkin overexpression. However, duty cycles of retrograde mitochondria were only 
modestly affected in PINK1 mutants compared with wild-type (Figure 3.2E). In addition, 
the anterograde velocities were not affected (Figure 3.2F), but retrograde velocities were 
reduced by the loss of PINK1, compared with wild-type (Figure 3.2G). Thus, the 
reduction in anterograde flux observed in the absence of PINK1 results in large part from 
reduced anterograde duty cycles, whereas the small reduction in retrograde flux can be 
explained by reduced velocities (Table 3.1). The net loss of retrograde retrieval predicted 



















Figure 3.2 PINK1 mutants show bidirectional mitochondrial motility changes with 
reduced flux and reduced anterograde duty cycles. A, Kymographs of axonal 
mitochondrial transport in segmental nerves of wild-type, PINK1B9, B9;P(Pink1) (genomic 
rescue), and B9;Parkin OE, displaying 5 min of movement; anterograde movement is 
toward the right. Vertical lines indicate stationary mitochondria. Scale bar, 10µm. B, C, 
PINK1 mutants show reduced flux in both anterograde (B) and retrograde (C) directions. 
This is rescued by expression of P(Pink1) and is partially rescued by parkin 
overexpression. D, E, PINK1 mutants show reduced duty cycles for anterograde 
mitochondria, with more time spent in pauses and less time moving in their primary 
anterograde direction (D). However, duty cycles of retrograde mitochondria are 
unchanged by loss of PINK1 (E). F, G, Mean run velocities of retrograde (G), but not 
anterograde (F), mitochondria are reduced in the absence of PINK1. The number of 
larvae analyzed for different genotypes is indicated on each bar. Each larval mean was 
calculated by averaging the values of at least five mitochondria for each direction, and 
tests were performed on the means of the larval means. Error bars indicate SEM. One-
way ANOVA with Bonferroni’s post-test was used for normally distributed data. Kruskal–
Wallis with Dunn’s post-test was used for non-normally distributed data. *p < 0.05, **p < 
0.01, ***p < 0.001; ns, non-significant differences. 
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3.2.3 Balance between Stationary and Moving Mitochondria remains unaltered in the 
Absence of PINK1 or in PINK1 Overexpression Conditions 
Another way in which mitochondrial flux in the axon could be modulated by the 
PINK1 pathway would involve the recruitment between persistently stationary and motile 
populations (Saxton and Hollenbeck, 2012; Devireddy et al., 2014). Indeed, it has 
recently been proposed that PINK1 stops the movement of depolarized mitochondria by 
stimulating degradation of Miro, a kinesin-mitochondria adaptor protein (Wang et al., 
2011; Liu et al., 2012).  
Thus, I analyzed the total mitochondrial population in motor axons of SNs to 
determine whether the loss or overexpression of PINK1 altered the fractions of moving 
and persistently stationary mitochondria. In wild-type nerves, the majority of axonal 
mitochondria are stationary (72.9 ± 1.2%; mean ± SEM); and of the 26% that are 
moving, 18.8 ± 1.3% move anterogradely and 7.4 ± 0.9% move retrogradely (Figure 
3.3A,B). In PINK1 mutants, by comparison, I did not observe any significant change in 
distribution between the stationary or moving populations (Figure 3.3B; Table 3.1). 
Furthermore, overexpression of PINK1 or parkin in a single copy had modest or no 
effects on either stationary or moving mitochondrial numbers, whereas overexpression 
of PINK1 in two copies actually caused an increase in the retrograde population only 
(Figure 3.3C). These data suggest that the balance between the persistently moving and 
stationary mitochondrial populations is virtually unaffected by PINK1 levels, even though 
mitochondrial motility behavior is affected by PINK1 loss. I did observe a significant 
increase in the small fraction of oscillating mitochondria (from ~1% to 4.3% of total 
mitochondria) in motor axons when PINK1 was overexpressed (Figure 3.3A,D). A similar 
motility phenotype has been observed previously in regions of vertebrate axons focally 
stimulated with nerve growth factor (NGF); there, it was attributed to the initiation of 
static docking interactions between mitochondria and the actin cytoskeleton in response 







Figure 3.3 Balance of moving and stationary mitochondria in PINK1 loss of 
function and overexpression conditions. A, Kymographs of axonal mitochondrial 
motility in A4 segmental nerves of wild-type, PINK15, PINK1B9, PINK1 OE(1), PINK1 
OE(2), and Parkin OE(1), displaying 2 min of movement; anterograde movement is 
toward the right. Vertical lines indicate stationary mitochondria. Arrows indicate the 
movement of anterograde mitochondria (green), retrograde mitochondria (red) in PINK1 
mutants, and oscillatory movements of mitochondria (brown) in PINK1 OE and parkin 
OE. Scale bar, 5µm. B, In wild-type segmental nerves, ~72% of mitochondria are 
stationary, with ~20% moving anterogradely and ~10% moving retrogradely. None of the 
PINK1 mutants showed a significant difference in percentage of either stationary or 
moving (anterograde, retrograde) mitochondria. C, Single-copy overexpression of PINK1 
OE(1) or parkin OE(1) also produces no change in the fraction of stationary 
mitochondria, whereas two-copy overexpression of PINK1 OE(2) actually increases the 
percentage of retrogradely moving mitochondria. D, Oscillating mitochondria, observed 
rarely in wild-type (<1%), increase significantly to ~3-4% in PINK1 OE(1) and PINK1 
OE(2). Number of larvae analyzed is indicated on each bar. Error bars indicate SEM. **p 
< 0.01, ***p < 0.001 (one-way ANOVA with Bonferroni’s post-test); ns, nonsignificant 





Table 3.1 Parameters of Mitochondrial Axonal Transport in Drosophila Motor 
Axons 
S.No Mitochondrial Parameters Wild-type PINK1B9 PINK15 
1 Flux (Number moving per minute)  
 Anterograde Flux 3 ± 1.2 1.8 ± 0.7 ↓ * 1.8 ± 0.5 ↓ * 
Retrograde Flux 2.4 ± 0.7 0.8 ± 0.5 ↓ * 1.5 ± 0.7 ↓ 
2 Duty cycles (%Time mitochondria 
spent) 
 
 Anterograde Mitochondria    
%time in Anterograde direction 71 ± 2.5 61 ± 6.3 ↓ 56 ± 3.4 ↓ * 
%time in Pauses 29 ± 2.6 38 ± 2.1 ↑ * 43 ± 3.0 ↑ * 
Retrograde Mitochondria  
%time in Retrograde direction 63 ± 3.7 54 ± 3.5 55 ± 3.6 
%time in Pauses 33 ± 2.5 41 ± 3.4 41 ± 3.8 
3 Velocities (µm/sec)  
 Anterograde Mitochondria 0.29 ± 
0.03 
0.27 ± 0.02 0.27 ± 0.004 
Retrograde Mitochondria 0.49 ± 
0.05 
0.35 ± 0.02 ↓ 
* 
0.39 ± 0.008 
↓ 
4 Percent Moving Mitochondria  
 Anterograde Mitochondria 19 ± 1.3 15 ± 1.3 20 ± 1.1 
Retrograde Mitochondria 7.4 ± 0.9 7 ± 0.8 6 ± 0.8 
 
Table 3.1 Parameters of Mitochondrial Axonal Transport in Drosophila Motor 
Axons 
In PINK1 mutants, reduced flux is caused due to changes in motility behavior of 
mitochondria: anterograde flux due to reduced anterograde duty cycles and retrograde 
flux due to reduced retrograde velocities. In addition, the reduction in flux is not caused 
due to changes in percent moving mitochondria as loss of PINK1 function do not affect 
the percent moving mitochondria in motor axons. Values represent mean ± SEM; 
affected parameters are indicated in red font with upward arrows (↑) for an increase and 
downward arrows (↓) for decrease; asterisks (*) indicate the statistically significant 





3.3 Mitochondrial Morphology in Motor Axons in the Absence of PINK1 or in 
PINK1 Over-expression conditions 
            Because PINK1 has been proposed to inhibit the fusion of damaged with healthy 
mitochondria via degradation of the fusion protein dMfn (Poole et al., 2010; Ziviani et al., 
2010), another prediction of the PINK1/Parkin model of mitochondrial quality control is 
that PINK1 mutants should show a shift of the fission-fusion balance toward fusion and 
thus accumulate longer mitochondria. 
3.3.1 Mitochondrial Lengths are unchanged in the absence of PINK1 
In motor axons of wild-type larva (Figure 3.4Ai), I observed that stationary 
mitochondria (1.3 ± 0.04 µm; mean ± SEM) were not significantly longer than moving 
mitochondria (anterograde, 1.21 ± 0.04 µm; retrograde, 1.24 ± 0.09 µm). When 
compared to wild-type, PINK1 mutants showed no significant difference in the mean 
lengths of either their stationary or moving mitochondria (Figure 3.4Aii, B–D). Deficient 
inhibition of fusion could also result in a small outlying population of longer organelles 
not detectable as a difference in means, so I compared the frequency distribution of 
mitochondrial lengths. Despite the appearance of a slight skew toward longer categories 
in PINK1 mutants, I found no statistically significant difference in the length distribution of 
stationary mitochondria (Figure 3.4E) (ns, nonparametric two-sample KS test). Thus, 
loss of PINK1 function did not result in detectable accumulation of longer mitochondria in 
motor axons. 
3.3.2 Mitochondria become Smaller in PINK1 Overexpression Condition 
Overexpression of PINK1 (Figure 3.4Aiii) significantly reduced the mean lengths 
of stationary mitochondria (1.11 ± 0.02 µm) (Figure 3.4B), without affecting the mean 
lengths of moving mitochondria (Figure 3.4C,D). Analysis of the stationary length 
distribution also showed more small mitochondria in PINK1 overexpression compared 
with wild-type (Figure 3.4E) (p < 0.001, nonparametric two-sample KS test). These 
results suggest that overexpression of PINK1, but not its loss, affected mitochondrial 







Figure 3.4 PINK1 loss does not shift fission–fusion balance toward longer axonal 
mitochondria.  
(A) Mitochondria in the axons of wild-type (i), PINK1B9 mutant (ii), and PINK1 OE(1) (iii). 
Scale bar, 5µm. Mean lengths of stationary (B), anterograde (C), and retrograde (D) 
mitochondria are determined for wild-type, PINK1 mutants, and PINK1 OE(1). Only 
PINK1 OE(1) produces a change, and this is a decrease in mean lengths of stationary 
mitochondria (B). (E) Frequency distribution of stationary mitochondrial lengths (µm) was 
analyzed for wild-type, PINK1B9, and PINK1 OE(1). (B-D) Number of larvae analyzed is 
shown on each bar. Error bars indicate SEM. *p < 0.05 (nonparametric Kruskal–Wallis 
test followed by Dunn’s post-test); ns, nonsignificant values compared with wild-type. 
Nonparametric two-sample KS test for frequency distribution (E), p < 0.001 for wild-type 











3.4 Mitochondrial Morphology in Motor Cell Bodies (CBs) in PINK1 Loss of 
Function 
3.4.1 Large Discrete Rounded Mitochondria in CBs in the absence of PINK1 
Even though mitochondrial lengths are unaffected in motor axons, mitochondrial 
morphology in motor CBs was indeed affected by PINK1 loss. Whereas mitochondria 
were organized as a filamentous reticulum in motor CBs in the ventral ganglion of wild-
type larvae (Figure 3.5Ai,Avi), PINK1 mutants show a subset of much larger, rounder, 
discrete mitochondria (Figure 3.5Aii,Avii, arrows). I quantified the percentage of CBs with 
these abnormally large mitochondria (defined as having an area of >2 µm2 in 2D 
projection) and found that the loss of PINK1 caused the formation of these abnormal 
mitochondria in ~60% of the CBs observed (Figure 3.5B) compared with only 8% in 
control wild-type larvae. Normal mitochondrial morphology was significantly restored by 
the expression of genomic levels of PINK1 or by the overexpression of parkin (Figure 
3.5B). These data suggest that mitochondrial morphology is altered in CBs in the 
absence of PINK1 function, probably due to defects in the fusion–fission steady state. It 
does remain possible that some of the large mitochondrial structures actually result from 
the clustering of many small, fragmented mitochondria that are not resolved individually 
by our methods. The rescue of mitochondrial defects in PINK1 loss-of-function mutants 
by parkin overexpression suggests that in the cell bodies, parkin is indeed acting 
downstream of PINK1 in a regulatory pathway, as indicated by genetic studies (Clark et 
al., 2006; Park et al., 2006).  
3.4.2 Overexpression of Yeast Complex I NDI1 Recovers the Mitochondrial Morphology 
in CBs 
The abnormal mitochondrial morphology in motor CBs in PINK1 mutants could 
have resulted from more discrete functional defects in electron transport chain (ETC) 
complex I, rather than overall organelle senescence. To determine this, the yeast 
alternative NADH oxidoreductase Ndi1p (NDI1) (Vilain et al., 2012) was overexpressed 
in PINK1 loss of function mutants (Figure 3. 5Av,Ax,B). NDI1 overexpression partially 
rescued the mitochondrial morphology in motor CBs of PINK1 mutants indicating that 
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ETC complex I functional defects could underlie the morphological changes (Figure 
3.5Av,Ax,B).  
 
Figure 3.5 PINK1 mutants show abnormal mitochondrial morphology in motor 
neuron CBs.  
(A) Images show mitochondrial morphology in motor neuron CBs of ventral ganglion in 
PINK1RV as control (i), PINK1B9 (ii), B9;P(Pink1) (genomic rescue) (iii), B9;Parkin OE 
(iv), B9;NDI1 OE (v), PINK15/+ as control (vi) for PINK15 mutants (vii), PINK15;P(Pink1) 
(genomic rescue) (viii), PINK15;Parkin OE (ix), and PINK15;NDI1 OE (x). Arrows in 
PINK1B9 and PINK15 mutants indicate abnormal, rounded mitochondria, in contrast to 
interconnected, reticular mitochondria in PINK1RV and PINK15/+ controls. Scale bar, 
5µm. B, CBs (%) with abnormal, large round mitochondria were quantified for PINK1RV, 
PINK1B9, B9;P(Pink1) (genomic rescue), B9;Parkin OE and B9;NDI1 OE and for 
PINK15/+, PINK15, PINK15;P(Pink1) (genomic rescue), PINK15;Parkin OE and 
PINK15;NDI1 OE. The mitochondrial morphology phenotype observed in PINK1 loss of 
function mutants was rescued by the expression of genomic levels of P(Pink1) or by 
parkin OE or by yeast alternative NADH oxidoreductase Ndi1P OE (NDI1 OE). Number 
of larvae analyzed is shown on each bar. Error bars indicate SEM. *p < 0.05, **p < 0.01, 





3.5 Mitochondrial Density is not affected in PINK1 Loss of Function Mutants 
One prediction of the PINK1 model of mitochondrial quality control (Youle and 
Narendra, 2011, Ashrafi and Schwarz, 2013) is that defective turnover should cause 
senescent mitochondria to accumulate in PINK1 mutant axons. Thus, I determined 
whether the loss of PINK1 causes an increased mitochondrial density in larval SN 
axons. Interestingly, I observed no significant change in the PINK1 mutants compared 
with wild-type (Figure 3.6A). This result could be explained if most mitochondrial quality 
control and turnover processes were localized to CBs. I therefore determined the 
mitochondrial volume in motor CBs of the ventral ganglion using 3D reconstruction of 
confocal images and found that, here too, the mitochondrial volume was very similar 
between PINK1 mutants and wild-type animals, giving no indication of accumulation of 
senescent organelles (Figure 3.6B). 
 
 
Figure 3.6 PINK1 loss does not lead to accumulation of mitochondria to higher 
densities in axons or CBs. A, Loss of PINK1 does not result in an increase in 
mitochondrial density in motor axons. B, Mitochondrial density in motor neuron CBs also 
remains unchanged in PINK1 mutants compared with PINK1RV control for PINK1B9 and 
PINK15/+ control for PINK15. Number of larvae analyzed is indicated on each bar. Error 
bars indicate SEM; one-way ANOVA with Bonferroni’s post-test, all are nonsignificant 
(ns); mutants compared with wild-type or control and PINK1;P(Pink1) or PINK1;Parkin 










Mitochondria are semiautonomous organelles with a complex life cycle 
encompassing biogenesis, transport, fission-fusion, and turnover. All these events of the 
mitochondrial life cycle are carried out in a coordinated fashion so as to maintain a highly 
functional mitochondrial population in cells. This is complicated further in neurons 
because of their large dimensions and functionally compartmentalized cell structure: 
synaptic end terminals with high energy demands are separated in space from the 
somatic compartment, where protein synthesis and degradation occur, by extremely long 
axons. Thus, neurons rely on axonal transport to re-distribute mitochondria over long 
distances, which may separate, in time and space, events that are closely coordinated in 
cells of more modest dimensions. However, a coherent model of mitochondrial turnover 
in neurons and its potential failures in neurodegenerative disease has arisen from 
studies involving PINK1/Parkin pathway. Inhibition of this pathway produces 
mitochondrial structural and functional defects in Drosophila muscle (Clark et al., 2006; 
Park et al., 2006; Morais et al., 2009) and mouse striatum (Gautier et al., 2008). In 
addition, PINK1 and parkin have been proposed to have a role in the segregation of the 
dysfunctional mitochondria for turnover by preventing their fusion with healthy ones via 
degradation of the mitochondrial fusion protein, Mfn (Poole et al., 2010; Ziviani et al., 
2010). Furthermore, PINK1 has been proposed to play a regulatory role in axonal 
mitochondrial motility, by targeting the motor-organelle linker protein Miro for 
degradation and thus halting the transport of dysfunctional mitochondria (Wang et al., 
2011; Liu et al., 2012).  
However, the role of PINK1/Parkin pathway in mitochondrial turnover has not 
been elucidated in the nervous system in vivo, under normal physiological conditions. In 
addition, very little is understood about the changes that occur in the mitochondrial life 
cycle when mitochondrial turnover is disrupted, particularly in neurons. If the proposed 
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model mechanisms of the PINK1 pathway in mitochondrial quality control are broadly 
valid in the complex environment of the nervous system, then they generate several     
specific phenotypic predictions: failures of turnover, accumulation of senescent 
mitochondria in the axons, defects in mitochondrial traffic, and a significant shift in the 
mitochondrial fission-fusion steady state. I have tested these predictions in vivo, by 
quantitatively determining mitochondrial membrane potential, density, motility behavior, 
and morphology within the Drosophila larval nervous system in PINK1 deletion mutants. 
Loss of PINK1 function causes a reduction in mitochondrial membrane potential in 
nervous system in vivo, consistent with proposed role of PINK1 in mitochondrial quality 
control, but does not cause the predicted increase in density or length in axons. 
However, PINK1 deletion causes large rounded abnormal mitochondrial morphology in 
cell soma. In addition, deletion or overexpression of PINK1 does not alter the balance 
between stationary and moving mitochondria in axons, contrary to the popular model of 
PINK1 in the degradation of Miro. Moreover, loss of PINK1 function disrupts the 
bidirectional mitochondrial transport specifically by increasing the pause times of 
anterograde mitochondria, and decreasing the velocities of retrograde mitochondria. 
These specific, differential effects on motility patterns of anterograde, and retrograde 
mitochondria have resulted in their reduced flux. Thus, my findings suggest that PINK1 
is required to maintain the normal mitochondrial metabolic state and bidirectional 
transport in axons, and for normal morphology in the CB, but not for regulating 
mitochondrial fusion or turnover in axons.  
4.1 Mitochondrial quality control does not show the expected signs of impairment 
in axons of PINK1-deficient nervous system 
Based on the proposed role of PINK1 in the tagging and turnover of senescent, 
depolarized mitochondria (Matsuda et al., 2010; Narendra et al., 2010), I tested the 
hypothesis that the loss of PINK1 function causes the dysfunctional mitochondria with 
low inner membrane potential (IMP) to accumulate in axons of the PINK1-deficient 
nervous system. The effect on IMP could manifest either as a general diminution of the 
mean IMP of the mitochondrial population or as a distinct outlying population with a 
significantly lower IMP. I observed the former (a modest reduction in IMP of the axonal 
mitochondrial population overall) and not the latter (Figure 3.1). This is consistent in part 
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with the proposed role of PINK1 in turnover and may reflect a protracted failure to cull 
neuronal mitochondria, whereas the appearance of a distinct outlying population with low 
IMP might be expected after short-term, acute PINK1 suppression. However, if 
senescent mitochondria accumulate in the axons of PINK1-deficient neurons, as 
predicted, then this should also have been apparent as both an increased density of 
mitochondria and a net diminution of their retrieval via retrograde transport to the cell 
body, a major site of turnover. However, I observed that mitochondrial density remains 
unchanged in the axons of PINK1-deficient neurons (Figure 3.6A). Though there was a 
reduction in retrograde delivery of mitochondria to cell body, I also observed the reduced 
entry of mitochondria anterogradely into axons. These changes in retrograde traffic were 
almost exactly balanced by those of anterograde mitochondria (Figure 3.2B,C), and did 
not cause an expected increase in organelle density in the axons of PINK1-deficient 
nervous system. 
 In addition, it is notable that if the current model of the mitochondrial life cycle is 
correct, then senescent mitochondria should manifest themselves as a small 
subpopulation with large inner membrane depolarization, available to be recognized and 
tagged by PINK1 for turnover. However, this study and others (Verburg and Hollenbeck, 
2008) have found that, under normal physiological conditions, neurons display a striking 
lack of variation in IMP among the mitochondria within a cell, and there is certainly no 
evidence for a small outlying population with low IMP. Even in Drosophila 
neurodegenerative disease models, only animals with severe dying-back neuropathy 
displayed gross depolarization of axonal mitochondria (Shidara and Hollenbeck, 2010). 
Also, in contrast to the localization of PINK1/Parkin onto majority of mitochondria 
reported in non-neuronal cells treated with uncouplers (Matsuda et al., 2010; Narendra 
et al., 2010), studies in neurons found that parkin is targeted to only a small fraction of 
depolarized mitochondria after photodamage or drug treatment (Ashrafi et al., 2014). 
Indeed, recent data show that this discrepancy in evidence for parkin recruitment to 
mitochondria in neuronal versus non-neuronal cells can be attributed to cell type-specific 
differences in bioenergetics (Van Laar et al., 2011). Upon treatment with uncouplers, 
parkin translocation to mitochondria was observed only in immortalized cell lines 
including HeLa cells and SH-SY5Y neuroblastoma cells that mainly depend on glycolysis 
for ATP, but not in neurons that depend on mitochondrial OXPHOS for ATP. However, 
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when HeLa cells were made to depend on mitochondrial ATP synthesis by growing in 
glucose-free, galactose-containing medium, CCCP treatment did not induce parkin 
translocation to mitochondria (Van Laar et al., 2011). Similarly, when yeast was cultured 
in non-fermentable carbon source and made to depend on mitochondrial respiration for 
ATP, mitophagy was not induced (Kanki and Klionsky, 2008). These results suggest that 
cellular bioenergetics play a very important role in the differential recruitment of parkin to 
mitochondria in cell type-specific manner, and thereby in the induction of mitophagy. 
Along with my data, this argues against a role for the PINK1-Parkin pathway in axonal 
mitochondrial turnover in the nervous system in vivo.  
An additional major proposed role of the PINK1 pathway in mitochondrial quality 
control is the regulation of the fission–fusion steady-state. Down-regulation of 
mitochondrial fusion protein opa1 has been shown to rescue the mitochondrial structural 
defects in PINK1-deficient Drosophila muscle (Poole et al., 2008). In addition, higher 
levels of the mitochondrial fusion protein mitofusin were detected in the PINK1-deficient 
tissue (Poole et al., 2010; Ziviani et al., 2010). Thus, it has been hypothesized that 
PINK1 targets the mitofusin of depolarized mitochondria for degradation, thus preventing 
fusion of senescent, low IMP mitochondria with other, fully functional neighbors (Poole et 
al., 2010), and thereby preserving the health of the population. Any imbalance of 
mitochondrial fusion–fission processes in axons will be apparent in mitochondrial 
morphology, as either longer mitochondria due to excessive fusion or small fragmented 
mitochondria due to higher rates of fission (Amiri and Hollenbeck, 2008; Cagalinec et al., 
2013). Thus, PINK1 mutants should display increased mitochondrial length, apparent 
either as a change in the population mean or perhaps only as an outlying, longer 
senescent population. Here, too, I found no evidence for this prediction in vivo: the mean 
mitochondrial lengths between normal and PINK1 mutant axons were identical for both 
moving and stationary organelles, and there was no outlying-longer population in the 
absence of PINK1 (Figure 3.4E). It has been shown in pancreatic cells that only healthy, 
functional mitochondria undergo the fusion process (Twig et al., 2008a). This report has 
shown that depolarized mitochondria are selectively inhibited from fusing with the 
functional mitochondrial network, and this is achieved by the degradation of 
mitochondrial fusion protein Opa1 (Twig et al., 2008a). However, in PINK1 mutants, a 
reduction in mitochondrial IMP seems unlikely to inhibit the fusion, as these mitochondria 
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do not show a drastic reduction in IMP, but rather a partial depolarization. Alternatively, it 
is possible that mitochondrial fusion-fission occurs only rarely in axons. Indeed, it has 
been recently reported that the rate of fusion-fission occurs at ~6 fold lower rate in axons 
compared to the somatic compartment (Cagalinec et al., 2013).  
4.2 Location of mitochondrial turnover 
Although the loss of PINK1 function does not affect mitochondrial morphology in 
motor axons, it is important to recognize that mitochondrial fusion–fission, and other 
quality control processes, probably occur only rarely in axons (Berman et al., 2009; 
Cagalinec et al., 2013). Despite clear evidence of axonal mitochondrial turnover in 
embryonic neurons in culture (Maday et al., 2012), it remains likely that much of the 
mitochondrial processing in the intact nervous system actually occurs in the somatic 
compartment (Cai et al., 2012). In this case, I would expect PINK1 deficiency to produce 
a phenotype not in axons, but mainly in the CBs. I did indeed observe that PINK1-
deficient CBs frequently contained large, rounded, abnormal mitochondria that are rarely 
seen in the normal nervous system (Figure 3.5). This could reflect defects in biogenesis, 
fission–fusion, turnover or some combination of these. Similar mitochondrial morphology 
has been reported in adult Drosophila dopaminergic neurons of PINK1 mutants, well 
before the stage of neuronal degeneration (Park et al., 2006). Moreover, the rescue of 
mitochondrial morphology by yeast NDI1 OE in larval motor neurons, as I observe, or by 
mitochondrial SOD2 overexpression in adult dopaminergic neurons of PINK1 deletion 
mutants (Park et al., 2006; Koh et al., 2012), argues for a connection between 
mitochondrial function and underlying morphological changes. It was notable, however, 
that, in the absence of PINK1, I did not observe the predicted increase in mitochondrial 
volume in CBs, which would result from defective turnover. Along with these data, the 
reduced entry of anterograde mitochondria into axons that I observed in mutants argues 
for a PINK1 role in mitochondrial biogenesis in the CB, possibly by interacting with the 
Parkin – PARIS (ZNF746) – PGC-1α pathway (Shin et al., 2011). PARIS, a zinc-finger 
protein has been shown to act as a transcriptional repressor of PGC-1α that works as a 
transcriptional co-activator of genes required for mitochondrial biogenesis (Shin et al., 
2011). In this study, elevated levels of PARIS are observed in mice with parkin 
knockdown. Consistent with this result, biochemical studies have also demonstrated that 
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PARIS protein levels are regulated by parkin via ubiquitination, and thereby targeting it 
for degradation by ubiquitin-proteasomal system (Shin et al., 2011). Parkin’s ubiquitin 
ligase activity has been shown to require phosphorylation by PINK1 (Matsuda et al., 
2010), thus PINK1 could have a role in mitochondrial biogenesis via a Parkin – PARIS 
(ZNF746) – PGC-1α pathway (Shin et al., 2011). Having a role in both mitochondrial 
biogenesis and turnover, PINK1-Parkin pathway could play a very important regulatory 
role in the maintenance of constant mitochondrial number, essential for the survival of 
neurons. 
Another proposed mechanism for PINK1-dependent mitochondrial quality control 
that is consistent with my in vivo data is one by which organelle components are 
repaired or replaced piecemeal, as required. Recent studies suggest a role for PINK1 in 
the maintenance of ETC complex I activity by phosphorylation (Morais et al., 2009; Vilain 
et al., 2012; Morais et al., 2014). Moreover, the complex I deficits in Drosophila PINK1 
mutants are rescued by overexpression of the mitochondrial chaperone TRAP1 (Costa 
et al., 2013; Zhang et al., 2013). In addition, misfolded proteins belonging to 
mitochondrial ETC complexes are accumulated in Drosophila PINK1 mutants (Pimenta 
de Castro et al., 2012) implying the role of PINK1 in maintaining the activity of 
chaperones. Furthermore, the PINK1/Parkin pathway has been shown to be involved in 
the selective elimination of damaged mitochondrial ETC proteins (Vincow et al., 2013). 
All these studies indicate the role of PINK1 in the maintenance of ETC proteins, and 
chaperones required for mitochondrial protein quality control. Thus, in neurons it is 
possible that the PINK1-Parkin pathway preserves mitochondrial function upstream of a 
role in overall mitochondrial turnover. This could include the maintenance of normal 
metabolism and ATP production, the failure of which could explain many aspects of the 
PINK1-deficient phenotypes I observe in vivo. I suggest that mitochondrial turnover via 
tagging and digestion of senescent organelles may be rare in mature axons. In this 
context, it is worth noting the recent in vivo evidence that axonal mitochondria can be 
degraded alternatively in adjacent glial cells following axonal evulsion (Davis et al., 
2014). From the analyses of electron microscopic sections of mouse optic nerve head, 
this study has demonstrated the delivery of axonal mitochondria via axonal membranous 
extensions into astrocytic processes. This delivery process is visualized by specifically 
expressing mitochondrially targeted fluorescent reporter only in retinal ganglion cells 
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(RGCs). The axonal mitochondrial reporter has been observed to colocalize substantially 
with lysosomes of astrocytes suggesting that axonal mitochondria are delivered for 
turnover in astrocytes (Davis et al., 2014). 
4.3 Mitochondrial transport is disrupted in PINK1-deficient nervous system 
Based on studies involving in vitro cell cultures treated with mitochondrial 
uncouplers, PINK1 is proposed to have a role in targeting depolarized mitochondria for 
turnover. In contrast to non-neuronal cells, one complex issue in neurons is that 
mitochondria spend the majority of their life-time in axons, and have to be transported to 
the site of turnover, the cell soma. If PINK1 has a role in mitochondrial turnover in 
nervous system in vivo under normal physiological conditions, then the loss of PINK1 
function should cause a failure in tagging of dysfunctional mitochondria in axons, and 
thereby reduction in their retrograde retrieval to the cell body for turnover. However, in 
PINK1 deletion mutants I observed a reduction not just in retrograde flux but also in 
anterograde flux. Interestingly, I found that these defects in flux have arised due to the 
differential effects of the loss of PINK1 on the motility behavior patterns of anterograde, 
and retrograde mitochondria. In PINK1 deletion mutants, velocities of retrograde 
mitochondria are specifically reduced, however leaving those of anterograde 
mitochondria unaffected. This suggests that PINK1 is probably involved in regulating the 
activity of dynein motor, as velocities indicate the motor activity. Recently, it has been 
shown that the abnormal activity of CDK5 in response to stress specifically disrupts the 
retrograde axonal transport via the phosphorylation of Ndel/Lis1 complex that regulates 
dynein motor (Klinman and Holzbaur, 2015). I propose that the specific effect on 
retrograde velocities in PINK1 mutants could possibly involve the regulation of dynein 
motor by the upregulated activity of CDK5 in response to stress.  
In addition, the duty cycles of only anterograde mitochondria are reduced: with a 
reduced fraction of time spent moving anterogradely, and a greater fraction of time in 
pauses, thereby reducing their processive anterograde motility. Anterograde motility has 
been shown to be regulated by multiple kinases via phosphorylation of motor protein 
subunits (Morfini et al., 2002; Morfini et al., 2004; Morfini et al., 2009b). A recent study 
has reported the elevated levels of GSK3β activity in the absence of PINK1 (Anichtchik 
et al., 2008). GSK3β has been shown to specifically inhibit the anterograde movement 
53 
 
via phosphorylation of kinesin light chain (KLC) that releases the kinesin-1 motor from 
organelle (Morfini et al., 2004). Thus, the specific disruption of anterograde mitochondrial 
motility in PINK1 mutants could possibly involve the regulation of organelle movement by 
GSK3β. 
4.4 Manipulation of the PINK1 pathway fails to control the stationary-motile 
balance in the axon 
A prominent hypothesized mechanism for regulating axonal mitochondrial motility 
proposes that PINK1 tags mitochondria with low IMP to induce degradation of their 
motor-organelle linker protein, Miro (Wang et al., 2011). According to this proposed 
model, I expect PINK1 OE to cause the recruitment of retrogradely moving mitochondria 
into stationary population or to cause complete cessation of movement. However, I 
observed that PINK1 OE(2) actually increases the percentage of retrogradely moving 
population and the overexpression of PINK1 or parkin in single copy do not alter the 
percentages of moving and stationary mitochondria (Figure 3.3C).  
In addition, I tested this proposed role of PINK1 in Miro degradation using PINK1 
deletion mutants. I hypothesized that PINK1 mutants would show enhanced transport 
and reduced pause times. However, I observed the opposite: PINK1 mutation disrupted 
the mitochondrial traffic specifically by increasing the pause times of anterograde 
mitochondria, and decreasing the velocities of retrograde mitochondria. Furthermore, I 
did not observe an increase in the percentage of moving mitochondria in PINK1 deletion 
mutants, and the fractions of stationary and motile mitochondria remain unaffected 
(Figure 3.3B). Thus, my analysis of mitochondrial motility suggests that PINK1 has a role 
in mediating the specific motility behaviors of both anterograde and retrograde 
mitochondria. It is possible that the use of PINK1-null mutants in my studies, rather than 
a PINK1 RNAi line (Wang et al., 2011; Liu et al., 2012), could account for different 
findings in mitochondrial motility. Because PINK1 OE is reported to completely halt 
motility in CCAP neurons (Wang et al., 2011), but not in motor neurons (Figure 3.3C) 
(Liu et al., 2012), it is also possible that PINK1 OE produces neuronal cell type-specific 
phenotypes. It is also notable that, in all reports, disruption of normal PINK1 levels 
affected not just anterograde motility, but also retrograde. Indeed, many studies of the 
modulation of axonal transport also show that experimental interventions ostensibly 
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targeted at one direction of movement actually yield effects on both directions (e.g., 
Pilling et al., 2006; Morfini et al., 2009b; Pigino et al., 2009; Russo et al., 2009; Morfini et 
al., 2013). Thus, the mechanisms of axonal transport regulation are complex and do not 
seem to involve a general PINK1-induced halting of anterograde traffic in vivo.  
In summary, I found that mitochondrial membrane potential is diminished in 
PINK1-deficient nervous system indicating the role of PINK1 in the maintenance of 
normal mitochondrial function. However, PINK1-deficiency has not resulted in an 
increase in axonal mitochondrial density as predicted based on the proposed role of 
PINK1 in tagging mitochondria for turnover. In addition, loss of PINK1 function caused a 
reduction in both anterograde and retrograde mitochondrial traffic with more specific, 
essentially balanced effects. Manipulation of PINK1 levels either by deletion or 
overexpression did not alter the balance between stationary and moving mitochondria, 
as opposed to the proposed model of PINK1 in the degradation of Miro. Furthermore, I 
did not observe an increase in mitochondrial length in axons as predicted from the 
hypothesized role of PINK1 in the segregation of dysfunctional mitochondria by 
preventing their fusion with healthy ones. However, PINK1 loss of function caused an 
abnormally large rounded mitochondria in neuronal soma in vivo. Surprisingly, PINK1 
deletion did not result in the predicted increase in mitochondrial volume in neuronal 
soma which is presumed to be the major site of turnover. Thus, these results suggest 
that PINK1 is required for the maintenance of a normal mitochondrial network in the 
soma in vivo, indicating that it plays a role there in mitochondrial biogenesis and/or 
fission–fusion processes.  
In conclusion, my findings indicate that PINK1 is required for normal 
mitochondrial function and bidirectional axonal transport, but not for mitochondrial 
turnover or fission–fusion control in axons in vivo as recently proposed (Youle and 
Narendra, 2011; Ashrafi and Schwarz, 2013). Thus, my results support the idea that 
mitochondrial turnover and fission–fusion in axons are organized differently in vivo, in an 
intact nervous system, than they are in vitro, in neuronal culture.  
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